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Abstract
Cardiovascular disease (CVD) causes the most deaths in the United States and is
disproportionately impacting certain groups more than others. A gap in the research
exists when focusing on national data for those who bear the highest burden of CVD
amongst people with hypertension when cardiovascular morbidity and mortality are
examined. There is also a need to investigate the relationships between key indicators for
CVD health disparities in people with hypertension. The purpose of this quantitative
study is to investigate the cumulative effect of key health disparities indicators such as
race, age, gender, education, and income using national-level surveillance data to
determine if there are significant differences in CVD morbidity and mortality outcomes
among people with hypertension. Systems theory is the theoretical foundation for this
research study. Two major research questions seek to determine if there are significant
differences in the selected CVD morbidity and CVD mortality outcomes in hypertensive
subpopulations who are ages 30 years and older who experience health disparities, and
the best group in the United States for hypertension when 3 or more of the health
disparities indicators intersect. Data were provided by NHANES between 1999–2010.
The results of multivariate analysis show that there are significant differences among
people with hypertension in morbidity and mortality CVD outcomes when three or more
health disparity indicators intersect. Positive social change can result when the findings
of this study are used to address health disparities in CVD and hypertension.
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Chapter 1: Introduction to the Study
Introduction
Cardiovascular disease (CVD) is the leading cause of death in the United States
(Guide to Community Preventive Services, 2014). It is estimated that a person in the
United States suffers from a heart attack every 43 seconds (CDC, 2016). There are known
risk factors for CVD (i.e., high cholesterol, smoking, and hypertension). Hypertension or
high blood pressure is a major risk factor for CVD that is often uncontrolled and
undetectable (Valderama, Gillespie, Coleman King, et al., 2012). There are certain
subpopulations in the United States who are disproportionately impacted by both CVD
and hypertension resulting in major health disparities (CDC, 2013).
Education, race and/or ethnicity, income, gender, and geographic location are
used to determine subpopulations in the United States who often bear the highest burden
of disease (Kreiger & Sydney, 1996; Liao, et al., 2011; and Opara, et al., 2013). These
subpopulations are experiencing health disparities that often lead to health inequities. For
example, Gupta (2011) conducted a study in Delaware and examined the prevalence of
multiple risk factors for CVD and found that a higher proportion of those from population
subgroups identified by socioeconomic status had multiple risk factors for heart disease
and stroke. The researcher found that prevalence of multiple risk factors was higher for
those who were older, less educated, and unemployed (Gupta, 2011). In another study by
Zimmerman and Anderson (2019), the researchers utilized the Behavioral Risk Factor
Surveillance System to determine if health equity has improved over the past 25 years
from 1993 to 2017 among adults in the United States. The researchers found a decline in
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health equity and health justice over time, as well as worse income disparities
(Zimmerman & Anderson, 2019). There are also examples of health disparities that are
linked to geographic location. O’Connor and Wellenius (2012) utilized data from the
Centers for Disease Control and Prevention (CDC) 2008 Behavioral Risk Factor
Surveillance System (BRFSS) to link health disparities to geographic location and they
found that the crude prevalence rate of coronary heart disease was higher among those
living in rural areas versus urban areas.
The purpose of my research study is to investigate the cumulative effect of key
health disparities indicators such as race, age, gender, education, and income using
national-level surveillance data to determine if there are significant differences in CVD
morbidity and mortality outcomes among people with hypertension . Systems theory is
the theoretical foundation. There are two research questions related to morbidity and
mortality of CVD among people with hypertension. They seek to determine if there are
significant differences in the selected CVD morbidity and CVD mortality outcomes in
persons who are ages 30 years and older who experience health disparities, and the best
group in the United States for hypertension, when 3 or more of the health disparities
indicators intersect.
This research study has the following potential positive social change
implications. First, I found few studies in the literature review that applied a health
equity lens to national-level hypertension and CVD surveillance data to highlight health
disparities. Next, the findings from this study will fill a gap in the research as it relates to
the impact of multiple risk factors for health disparities on the CVD health outcomes
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among persons with hypertension. According to Agurs-Collins, et al. (2019), who
examined the impact of multilevel interventions to reduce health disparities, interventions
that focus on only single or individual-level factors are limited in their impact. The
current study will contribute to the knowledge base in public health and clinical practice
by highlighting the need to consider the cumulative effect of multiple health disparities
indicators on those with hypertension when planning and implementing interventions.
The major sections that will be covered in this chapter are the introduction,
statement of the problem, purpose of the study, research questions and hypotheses,
definitions of theoretical constructs, definition of terms, significance, assumptions and
limitations, and summary.
Background
Numerous state- and local-level research studies have been conducted to examine
the prevalence of cardiovascular diseases, as well as hypertension, and the associated risk
factors on the state and local levels (Andersen & Jensen, 2013; Liao, et al., 2011).
However, there is a gap in the research related to the impact of three or more
demographic characteristics associated with health disparities on the CVD health
outcomes among persons with hypertension. Race, gender, education, age and income
are the key demographic characteristics which are risk factors that are associated with
CVD-related health disparities.
Hypertension
During my review of the hypertension literature, I found few studies that applied a
health equity lens to national level hypertension data, compared it with cardiovascular
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morbidity and mortality data, and examined the cumulative effect of multiple health
disparities indicators on individuals with hypertension. Hypertension has been found to
disproportionately affect certain subpopulations. In one example publication, the
researchers examined racial/ethnic disparities in awareness, treatment, and control of high
blood pressure by hypertension stages using the National Health and Nutrition
Examination Survey (NHANES) during the period of 2003-2010 (Valderama, et al.,
2012). The researchers found that the proportion of Mexican-Americans and Blacks with
Stage 1 and Stage 2 hypertension was greater than for Whites. Stage 1 hypertension is
140–159 systolic or 90–99 diastolic and Stage 2 hypertension is 160 or higher systolic or
100 or higher diastolic (National Heart, Lung and Blood Institute, 2012). However, the
researchers made no efforts to further examine the health inequities that were identified
in the study. A similar study is needed for the impact of hypertension on CVD health
outcomes.
Loustalot, et al. (2014) also conducted a study in which they examined race.
They found that mortality rates for hypertensive heart disease among Blacks were
significantly higher than Whites in 2010 (50.9 per 100,000) when they examined the
trends in mortality by subtypes of heart disease in the United States. The Framingham
study was the first major observational study that included substantial numbers of
women. It has also been central to the development of the notion of absolute risk and the
importance of blood pressure alongside other risk factors (Turnbull, 2010).
Hypertension is a major cause of disparities in mortality between Blacks and
Whites in the United States because of the differences in prevalence and in hypertension
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control (Opara, et al., 2013; Satcher, 2008;). Hypertension disproportionately impacts
some groups’ burden of cardiovascular disease more than others by beginning earlier in
life and being more difficult to control. For example, a 2018 study found that the
cumulative incidence of hypertension by the age 55 years was 75.5% in Black men,
75.7% in Black women compared to 54.5% White men, and 40.0% in White women
(Thomas, et al., 2018). In addition to race, gender was found to be linked to disparities in
hypertension in the literature. For example, using a cohort study, Ford (2011) sought to
examine the change in the all-cause mortality rate among people with and without
hypertension in the United States and whether any such changes differed by gender or
race. The researcher found that the mortality rate was higher among hypertensive adults
than non-hypertensive adults, among hypertensive men than hypertensive women, and
among hypertensive Blacks than hypertensive Whites (Ford, 2011).
CVD. All heart disease, coronary heart disease, acute myocardial infarction, and
cardiac dysrhythmia are the CVD morbidity and mortality health outcomes for the
research study. Race has been found to have a negative impact on CVD outcomes and
risk factors among certain subpopulations in the United States. For example, Liu, et al.,
(2011) found that Hispanics and non-Hispanic Blacks were more likely to have
uncontrolled blood pressure (BP; Hispanics odds ratio [OR]: 1.58, 95% confidence
interval [CI]: 1.21-2.07; Blacks OR: 1.42, 95% CI: 0.21-1.67) and elevated glycosylated
hemoglobin (Hispanics OR: 2.70, 95% CI: 1.89-3.87; Blacks OR: 2.17, 95% CI: 1.702.77). The literature was reviewed to investigate the impact of age as a risk factor for
CVD and hypertension. A recent study by Gupta (2014) analyzed multiple risk factors as
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well as self-reported CVD prevalence overall and discussed the differences in prevalence
by age. The prevalence of multiple risk factors was higher for the aged, less educated,
and unemployed (Gupta, 2014).
A review of the literature associated with the impact of education on hypertension
and CVD was conducted. There has been a long-standing inverse relationship between
education and mortality that has strengthened substantially at the end of the 20th century
(Cutler, et al., 2011). A cross sectional study using the 2006 BRFSS to investigate
education was conducted (Kelly & Weitzen, 2010). After adjusting for confounders,
respondents with less than a high school education had 1.61 (95% CI: 1.41-1.83) times
the odds of having had an MI compared to college graduates. According to the
researchers’ findings, participants with a high school education and those who completed
some college or technical school were 1.22 times more likely to have had a myocardial
infarction in comparison to college graduates (Kelly & Weitzen, 2010).
The relationships between income and hypertension, as well as CVD, were
reviewed in the literature. The ability to obtain health insurance in the United States is
more commonly linked to the ability to have a source of employment that provides health
care coverage. One major research study found that: (a) the prevalence of hypertension
and elevated LDL cholesterol was similar for the insured and uninsured, (b) the
proportion of those who obtained treatment and achieved control of these risk factors was
lower among the uninsured, and (c) uninsured men and women were less likely to be
treated for hypertension (Brooks, et al., 2010).
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There were specific subpopulations (i.e., non-Hispanic Blacks, low income, and
low education) who were the most impacted when I examined the indicators (Ritchey, et
al., 2014; Ford, 2011). Additionally, I found that there were few research studies that
examined CVD and hypertension on the national level. In these studies, the researchers
examined some of the indicators also (Liao, et al., 2012; Ritchey et al., 2014). However,
I did not find any recent studies that examined the cumulative effect of the health
disparities indicators for CVD among people with hypertension on a national level.
Problem Statement
According to the CDC (2013), hypertension is a leading cause of CVD. Both
CVD and hypertension are disproportionately impacting certain subpopulations in the
United States, resulting in major health disparities (CDC, 2013). I found very few studies
that applied a health equity lens to national level data amongst people with hypertension,
compared it with cardiovascular morbidity and mortality, and investigated the relations
between numerous indicators for health disparities. The application of a health equity
lens (or focusing first on those who bear the highest burden of the disease) is a new
concept. The health equity lens has not been widely written about and no formal
definition currently exists for it.
A gap exists in the literature as it relates to the analysis of national CVD event
data for populations who are bearing the highest burden of the CVD by culture,
socioeconomic status, and geographic region (Schieb, et al., 2013). Sentinel observational
studies such as the Framingham Study, as well as other landmark observational studies,
have played key roles in establishing the link between hypertension and many
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cardiovascular diseases (Turnbull, et al., 2010). The link between hypertension and CVD
is created by demonstrating that the association between high blood pressure readings and
cardiovascular risk was continuous, linear, and consistent across different age groups and
for a range of major cardiovascular events (Lalonde, et al., 2012). The Framingham
study was integral in the development of the concept of absolute risk and the importance
of blood pressure alongside other risk factors (Turnbull, et al. 2010). There were other
important studies such as Ritchey, et al.’s (2014) investigation of the mortality trends in
heart disease that established the foundation for much of this research. I was able to find
numerous examples of recent CVD morbidity and mortality literature, such as the study
by Yang, et al. (2015) in which the researchers examined the racial, sociodemographic,
and state-level disparities in heart age among U.S. adults who are 30 years and older.
Schieb, et al. (2013) described the disproportionate number of death rates from heart
disease, stroke, and hypertensive disease related to race and geographic location in the
United States.
In this study, I have expanded the literature by investigating numerous health
disparities indicators for CVD among people with hypertension and examining the
cumulative effect of three or more health disparities indicators. There were previous
studies that had similar foci. For example, data from the Multiple Cause of Death Files
during 1999-2013 were compiled from 57 vital statistics jurisdictions (CDC, 2015).
When gender and age were examined, the researchers reported that the average annual
rate of first CVD events rises from three per 1,000 men at 35-44 years-old to 74 per 1,000
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men at 85-94 years-old with comparable rates found to occur 10 years later in life among
women (CDC, 2015).
Purpose of the Study
In this quantitative cross-sectional study, I utilized national surveillance data to
explore the cumulative effect of demographic characteristics such as race, gender, age,
education, and income to determine if there are significant differences in CVD morbidity
and mortality outcomes among hypertensive subpopulations that are linked to CVD and
hypertension health disparities. A hypertensive subpopulation is defined in the following
three ways: (a) an average systolic blood pressure (SBP) ≥140 mmHg;, (b) an average
diastolic blood pressure (DBP) ≥90 mmHg, or (c) currently using blood pressure
lowering medication (Valderama, et al., 2010). The independent variables for the
research study were education level, age, household income, race/ethnicity, body mass
index (BMI), and gender. The dependent variables were CVD morbidity –
hospitalizations for pain or discomfort in the chest and coronary heart disease, acute
myocardial infarction, heart failure and cardiac dysrhythmia diagnoses. CVD mortality –
death as a result of coronary heart disease, acute myocardial infarction, heart failure and
cardiac dysrhythmia diagnoses. Covariate variables that were also considered are
smoking, cholesterol levels, and hemoglobin A1-C levels.
Research Questions and Hypotheses
I examined the following research questions and hypotheses in this research
study.
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Research Question 1 (RQ1): Are there significant differences in the selected CVD
morbidity outcomes between hypertensive subpopulations, adults who are 30 years and
older, experiencing health disparities and the best group (i.e., the subpopulation with the
best CVD morbidity outcomes) in the United States for hypertension and when three or
more indicators (race, gender, education, age and income) intersect? The following
variables that are relevant include: CVD morbidity as a dependent variable; education
level, household income, race/ethnicity, body mass index (BMI), and gender are the
independent variables. Other covariates are hypertension medications, taking
cardiovascular medications, smoking, and cardiovascular fitness.
Null Hypothesis (H01): There are no significant differences in the selected CVD
morbidity outcomes between hypertensive subpopulations experiencing health disparities
and the best group with hypertension in the United States when three or more indicators
intersect.
Alternative Hypothesis (Ha1): There are significant differences in the selected
CVD morbidity outcomes between hypertensive subpopulations experiencing health
disparities and the best group with hypertension in the United States when three or more
indicators intersect.
Research Question 2 (RQ2): What are the significant differences in CVD
mortality outcomes between hypertensive subpopulations experiencing health disparities
and the best group (i.e., the subpopulation with the best CVD mortality outcomes) with
hypertension in the United States when three or more indicators (race, gender, education,
age and income) intersect? The following variables that are relevant to this question
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include: CVD mortality as a dependent variable; education level, household income,
race/ethnicity, BMI, and gender are the independent variables. Other covariates are
hypertension medications, taking cardiovascular medications, smoking, and
cardiovascular fitness.
Null Hypothesis (H02): There are no significant differences in CVD mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group with hypertension in the United States when three or more indicators intersect.
Alternative Hypothesis (Ha2): There are significant differences in CVD mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group with hypertension in the United States when three or more indicators intersect.
Theoretical and Conceptual Framework for the Study
I used systems theory as the theoretical framework for this cross-sectional
observational study. Systems theory originated from the notion that the interrelations of
multiple perspectives from complex systems should be taken into consideration in public
health (Leischow & Milstein, 2006). The ability to simultaneously explore these
connections among different components and among different subareas on the macrolevel is a major focus of systems theory.
My emphasis in this study on the cumulative effect of indicators for health
disparities is in alignment with systems theory’s focus on the inter-relations of multiple
components. I used systems theory in this study’s macro-level focus on CVD outcomes
among people with hypertension across the United States by examining the impact of
numerous health disparities indicators on CVD morbidity and mortality. The reliance on
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simulation (or modeling in order to examine relationships) and numerous variables are
key components of this theory that align with the approach and research questions of this
study. A more detailed explanation of Systems theory and its relation to the research
study will follow in Chapter 2.
In this research study, I sought to determine if relationships exists between
numerous selected components or indicators using the principles contained in systems
theory for a large study population to determine if there are significant differences in
CVD morbidity and mortality outcomes among hypertensive subpopulations
experiencing health disparities in comparison to people with hypertension who do not
experience health disparities. The intersectionality of multiple health disparities
indicators (i.e., race, gender, age, education, and income) amongst hypertensive
subpopulations can also be examined using this method. In systems theory, Leischow
and Milstein (2005) described the emphasis on relationships and the desire to obtain a
larger, more connected understanding are critical to this study.
Traditionally, cardiovascular and hypertension morbidity and mortality data are
examined based on each of the indicators individually. According to the Guide for
Community Preventive Services (2015), nearly half of Americans show at least one of
three key CVD risk factors which are hypertension, uncontrolled high levels of lowdensity lipoprotein cholesterol (LDL), and smoking. LDL and smoking are covariates
while hypertension is the major focus for this study. Uncontrolled hypertension is a
major concern for many of the persons with hypertension. One national study of 36
million U.S. adults found that approximately 39% were unaware of the fact that they are
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hypertensive, 16% knew about their hypertensive status but were not on medication, and
45% were taking medicine but did not have their blood pressure under control
(Valderama, Gillespie, et al., 2012). There are demographic factors that must be
considered in order to explain why certain subpopulations are struggling to control their
hypertension, and thus prevent morbidity and mortality associated with CVD. By
preemptively considering the demographic and epidemiologic findings to prioritize those
who were identified as being disproportionately impacted by hypertension, I applied a
health equity lens to this research study. In this quantitative study, I incorporated a health
equity lens and systems theory into its approach in order to address these issues. The
connections among these key elements will be examined in more detail in Chapter 2.
Nature of the Study
The nature of this research study was quantitative and I used a cross-sectional
design. I used quantitative data that has been previously collected over a period of 4 years
from a large sample of study participants to rigorously analyze data in a timely manner
from a national surveillance study. I used CVD event surveillance data and secondary
data analysis to respond to the research questions. The key study variables included:
dependent variables such as CVD morbidity and mortality variables. Independent
variables were: education level, household income, race/ethnicity, body mass index
(BMI), and gender. Having hypertension was an inclusion criterion for this study. Other
covariates were: hypertension medications, taking cardiovascular medications, smoking,
and cardiovascular fitness.
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I analyzed secondary data from previously collected data that was derived from a
sample of the National Health and Nutrition Survey (NHANES) 1999-2010 participants
to explore potential differences in health outcomes among subpopulations with
hypertension. These participants may have had varying indicators for health disparities.
I analyzed the data using SAS to perform the following analyses: descriptive statistics,
bivariate analysis, multivariate analysis, and regression modeling.
Definitions
Covariates: Are “any of two or more random variables exhibiting correlated
variation” (Merriam-Webster, 2016). Smoking, elevated cholesterol and obesity are
examples of covariates.
Dependent Variables: “A mathematical variable whose value is determined by
that of one or more other variables in a function” (Merriam-Webster, 2016). Dependent
variables in the research study may include coronary heart disease, acute myocardial
infarction, and cardiac dysrhythmia.
Health Disparity: “a particular type of difference in health (or in the determinants
of health that could be shaped by policies) in which disadvantaged social groups
systematically experience worse health or more health risks than do more advantaged
social groups” (Braverman, 2009).
Health Equity: “the absence of avoidable or remediable differences among groups
of people, whether those groups are defined socially, economically, demographically, or
geographically” (World Health Organization, 2015).
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Health Equity Lens: The application of a health equity lens is a new concept that
has not been widely written about and no formal definition currently exists. A health
equity lens is applied when the researcher or practitioner proactively analyzes the
epidemiological findings to implement interventions and/or conduct research that
prioritizes those who were identified as being disproportionately impacted by a disease.
Hypertension: A person is considered to have hypertension in one of the
following three ways: 1) an average systolic blood pressure (SBP) ≥140 mmHg; or 2) an
average diastolic blood pressure (DBP) ≥90 mmHg; or 3) currently using blood pressure
lowering medication (Valderama, et al., 2010).
Independent Variables: “A mathematical variable that is independent of the other
variables in an expression or function and whose value determines one or more of the
values of the other variables” (Merriam-Webster, 2016). Examples of independent
variables are the demographics in the research study.
Systems Theory: “an interdisciplinary theory that requires merging of multiple
perspectives and sources of information and deals with complex systems in technology,
society, and science” (Best, et al., 2003).
Assumptions
I made the aassumptions by and about subpopulations with hypertension. The
following misconceptions among hypertensive populations are discussed below.
Contracting high blood pressure is assumed to be inevitable amongst some people with
hypertension. There is a belief that a hypertension diagnosis can only be treated and
controlled by medication. Because hypertension often has no symptoms, then treatment
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is not a priority. Some persons with hypertension believe that there is no cure for
hypertension. Some medical providers believe that the non-compliance to medication of
certain subpopulations related to hypertension and CVDs cannot be helped. This is a
major misconception that exists among some providers.
These assumptions are important to keep in mind because many of them are held
by the subpopulations who are disproportionately impacted. The finding from the
research study can raise the awareness of the populations by addressing these
misconceptions. These assumptions may assist in building the case for applying a health
equity lens to interventions and addressing the social determinants of health by providers
and public health practitioners that are associated with hypertension and CVDs.
According to the Office of Disease Prevention and Health Promotion (2020), “social
determinants of health reflect the social factors and physical conditions structural
conditions in which people are born, live, learn, work, worship, play, and age”
(Paragraph 6). These are recognized as critical determinants of health and health
disparities.

Scope and Delimitations
There is a drastic need to address the multiple risk factors related to CVD health
outcomes that disproportionately impact certain hypertensive subpopulations in the
United States. The specific aspects of this research problem will be addressed in this
research study. They include: demographic indicators such as race, gender, age,
education, and income; CVD health outcomes (i.e., morbidity and mortality);
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hypertension as a major risk factor; and the cumulative effect of the indicators of CVD
among people with hypertension on a national level.
The populations who are included in the research study are large samples from the
United States population that were extracted from the NHANES survey. Adult
respondents from all races and ethnicities that are 30 years and older who were diagnosed
with hypertension were sampled. Individuals who were not diagnosed with hypertension
and were younger than 30 years-old were excluded. In addition to age, the sample will be
further categorized by education, gender, race or ethnicity, and income.
There were theories and concepts such as the Social Ecological Model and
empowerment that are relevant to this study but were excluded because a broader
approach was needed. The Social-Ecological model is a multi-level approach that
considers the different domains of influence and provides an overarching framework for
understanding the interrelations among diverse personal and environmental factors
(Fleury & Lee, 2006). This model spans across the following categories: intrapersonal
resources, interpersonal resources, and community and environmental resources (Fleury
& Lee, 2006). Empowerment is defined as “a social action process for people to gain
mastery over their lives and the lives of their communities” (Batholomew, et al., 2011,
p.1). It is important to ensure that the needs of all sub-groups are met when the
populations are diverse. Empowerment provides a means for those sub-groups who have
been marginalized to regain a sense of control and awareness of their health outcomes in
health promotion. Additionally, the findings from this study can be generalized to
persons in the general United States population who are either hypertensive, or at-risk for
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hypertension and CVD. The sample size is large enough to be applicable on the micro,
meso, and macro levels. It also allows practitioners to translation the research findings to
practice.
Limitations
This correlational study focused on the relationships between the demographic
variables related to health disparities, hypertension and CVD. Causation cannot be
assessed for studies of this type. Internal validity is weaker for correlational than for
experimental designs. The health interview portion of the data collection relies on the
participant to remember specific events. Difficulty with memory among the participants
is a limitation with cross sectional studies of this type. This may result in inaccurate or
biased recall.
The ability to recall the sequence of events can pose a problem. There are also
confounder variables, such as smoking, that may influence CVD outcomes which were
not examined in this research study. This did not significantly impact the results of this
study because many of the confounders such as smoking are not as closely linked to
hypertension, which is an inclusion criterion for this study. According to the American
Heart Association (2016), the connection between smoking and hypertension is still being
determined. This study employed multivariate analysis and regression analysis to
determine the direction of the relationship between variables. For the purposes of this
study, a correlational design was appropriate despite its limitations because the intention
of this study is to determine if a relationship exists between numerous variables.
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Significance
This research study can potentially contribute to the scientific evidence-base by
identifying and describing national cardiovascular and hypertension health disparities
using specified indicators (i.e., race and/or ethnicity, education, income, gender, and age)
among individuals within certain subpopulations in the United States. The following
CVD evidence gaps that were identified by the Community Preventive Services Task
Force were explored in this study: large scale studies; more diverse populations;
information on socioeconomic status (SES); and reporting of morbidity and mortality
outcomes (Guide to Community Preventive Services, 2012). This study helps to fill the
large scale studies gap by including a much larger sample from a national-level data
source. The need for more diverse populations and SES information was met in this
study because of its emphasis on examining CVD and hypertension data from
subpopulations who are from diverse races and/or ethnicities, education levels, and
incomes. This study examined the socioeconomic and demographic information from
national data of subpopulations who are the most at-risk for CVD. By focusing on the
cumulative effect of the major risk factors, this study expands the knowledge base by
identifying those variables that converge to place certain persons with hypertension at an
increased risk for morbidity and mortality related to CVD. The findings from this study
informed efforts such as policies, interventions, and resources allocated to reduce
cardiovascular events and hypertension health disparities by clinical and public health
practitioners.
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This study has the potential to contribute to positive social change by highlighting
the CVD and hypertension-related health disparities that are faced by those who are
commonly under-resourced, under-represented, and marginalized. The inclusion of
systems theory promotes the “big picture perspective” and results in a more diverse
approach to collaboration and data collection. Organizations from academia, medicine,
and public health could form better collaborations. It would also lead to gathering and
analyzing different types of data (i.e., behavioral and environmental) and integrating that
data and interpreting it. It will also assist researchers and practitioners in their efforts to
understand those subpopulations who bear the highest burden of CVD events and
hypertension in the United States by applying a health equity lens, as well as
implementing tailored approaches.
Summary
Chapter 1 discussed the need to analyze national CVD event data for hypertensive
subpopulations in the United States who are bearing the highest burden of CVD
morbidity and mortality. The cumulative effect of those risk factors that are linked to
health disparities among those people with hypertension who are most at risk for CVD
morbidity and mortality is an important component of this research study that was
described. The purpose of the study, research questions, hypotheses, definitions,
significance, scope, limitations, and significance were also examined. For the indicators
in certain subpopulations, I found that morbidity and mortality health disparities existed
for CVD and hypertension.
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Chapter 2 provides a detailed review of the existing literature associated with
CVD outcomes among people with hypertension in the United States who are at
increased risk. The chapter will begin with literature associated with the theoretical basis
for the research study. Systems theory is the theoretical basis for this study.
Cardiovascular diseases, hypertension, health disparities, health equity, geographic
location, race, age, gender, education, and income, will be further examined in the
literature review. The sections of this literature review include: the Introduction,
Literature Search Strategy, Theoretical Foundation, Literature Review Related to Key
Variables and/or Concepts, Implications of Past Research on Present Research, and the
Summary. The chapter will end with implications of past research and its influence on
this research.
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Chapter 2: Literature Review
Introduction
In this literature review, I discuss the need for continued research concerning the
cumulative effect of indicators (i.e., race, gender, education, income, and geographic
location) within certain subpopulations that lead to CVD morbidity and mortality
associated with hypertension in the United States. In this quantitative study,
subpopulations refer to the persons from the national samples or demographic groups
when the population data of the United States is disaggregated. CVD health disparities
have been among the most serious public health problems in the United States (Mensah,
2005). According to the American Heart Association (2011), CVD morbidity can include
numerous heart problems such as strokes, heart failure, arrhythmia, and heart attacks.
Cardiovascular mortality is defined as deaths among people with an underlying cause of
ischemic heart disease from the following International Classification of Diseases, 10th
Revision (ICD-10) codes: cerebrovascular disease (stroke) (I60–I69), hypertensive
disease (I10–I15), or chronic rheumatic heart disease (I05–I09; Macinko & Elo, 2009).
In this study, I focused on cerebrovascular disease (stroke), hypertension, and chronic
rheumatic heart failure among adults who are 30 years and older.
The purpose of this quantitative study was to investigate the cumulative effect of
indicators (i.e., age, race, gender, education, and income) using surveillance data from
across the United States to determine if there are significant differences in CVD
morbidity and mortality outcomes among hypertensive subpopulations that are linked to
CVD and hypertension health disparities. A health disparity is defined as “a particular
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type of difference in health (or in the determinants of health that could be shaped by
policies) in which disadvantaged social groups systematically experience worse health or
more health risks than do more advantaged social groups” (Braverman, 2009, p. A91).
There are widening CVD health disparities detected across the United States over the past
30 years in population subgroups identified by race, ethnicity, gender, socioeconomic
status, educational level, and geography (Mensah, 2005).
There is a link between hypertension and the risk of many cardiovascular
diseases. Sentinel observational studies such as the Framingham Study, as well as other
landmark observational studies, have been instrumental in examining this relationship by
demonstrating that the association between blood pressure and cardiovascular risk was
continuous, linear, and consistent across different age groups and for a range of major
cardiovascular events (Lalonde, et al., 2012). The Framingham study has played an
important role in the development of the notion of absolute risk and the importance of
blood pressure alongside other risk factors (Turnbull, et al. 2010). In addition to the
Framingham Study, there were other seminal studies such as Ritchey, et al.’s (2014)
examination of the mortality trends in heart disease that established the foundation for
much of this research. Numerous examples of recent literature were also found, such as
the study by Yang, et al. (2015), in which the researchers examined the racial,
sociodemographic, and state-level disparities in heart age among U.S. adults who are 30
years and older. In another study by Schieb, et al. (2013), the researchers described the
disproportionate number of death rates from heart disease, stroke, and hypertensive
disease linked to race and geographic location in the United States.
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In this review, I examined literature associated with systems theory, which is the
theoretical basis for this study, as well as cardiovascular diseases, hypertension, health
disparities, health equity, geographic location, race, age, gender, education, and income.
The major sections of this chapter include: the Introduction, Literature Search Strategy,
Theoretical Foundation, Literature Review Related to Key Variables and/or Concepts,
Implications of Past Research on Present Research, and the Summary.
Literature Search Strategy
To search the literature, I used three databases and search engines as the primary
resources of information. The scope of the literature review spanned from 2005 to 2019.
I searched peer-reviewed journal articles, literature reviews, book chapters, and
commentaries. Medline was a major source of biomedicine and life sciences journals.
PubMed is a larger database with biomedical literature from MEDLINE, life science
journals, and online books. I also used CINAHL to search for journals from the fields of
nursing and allied health. The citations for all literature used was stored in the
EndNoteX7 reference library.
To perform the literature review, the independent variables (race, gender,
education, income, and geographic regions of the United States) and dependent variables
(cardiovascular disease morbidity, cardiovascular disease mortality, hypertension
morbidity, and hypertension mortality) formed the basis of the key word search. I
utilized a specific search strategy using cardiovascular disease, hypertension, mortality,
morbidity, United States, trends, surveillance, epidemiology, health disparities, ethnic
disparities, racial disparities race, gender, education, income, geographic region, and
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health inequities as key search terms to retrieve the relevant literature. I used a variety of
combinations when searching for the key words.
Theoretical Foundation
Systems Theory
I used systems theory as the theoretical framework for this cross-sectional
observational study. The origin of systems theory in public health is derived from the
systems approach which is a paradigm that focuses on the interactions among different
components versus a single element (Leischow & Milstein, 2006). The Institute of
Medicine made key recommendations regarding systems approaches in a 2010 report
from (For the Public’s Health: The Role of Measurement in Action and Accountability)
to improve health data analysis and reporting (Yang, et al., 2015). According to
Leischow and Milstein (2006), being aware of the wider context and transdisciplinary
thinking are also important in the systems approach (Leischow and Milstein, 2006). In
addition to transdisciplinary thinking, the ability to take multiple perspectives from
complex systems is also needed. Systems theory is defined as “an interdisciplinary
theory that requires merging of multiple perspectives and sources of information and
deals with complex systems in technology, society, and science” (Best, et al., 2003. p.
S207).
This study’s emphasis on the cumulative effect of indicators for health disparities
is in alignment with Systems theory’s focus on multiple components. For example,
Systems theory’s particular emphasis on multiple variables can be transferred to the
indicators for health disparities in this study. The states, as well as regions of the United
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States, and the hypertensive subpopulations that are impacted by the indicators for health
disparities make up the system in this study. According to Lehrer and Eddie (2013), a
system is defined as a variety of elements that interact with one another to form a whole
entity. The unique parts or elements are not separated from each other and the
characteristics of the whole entity cannot generally be inferred from characteristics of its
components (Lehrer and Eddie, 2013). There are two major theoretical propositions that
are appropriate to the application of Systems theory in this study. Its reliance on
simulation and numerous variables are the two propositions. According to Green (2006),
systems theory relies on simulation rather than the controlled trial as the major source of
evidence. Additionally, it treats numerous variables as a resource to be used for further
evaluation than as adversaries to be controlled. The intent of this study is to analyze
multiple indicators and to generalize from large samples to the U.S. population. Green
(2006) stated that systems science can “help us unravel the complexity of causal forces in
our varied populations and the ecologically layered community and societal
circumstances of public health practice” (p. 406).
It is important to ensure that Systems theory is related to the study’s research
questions. The research questions for this research study will test the cumulative effect
of several indicators that lead to CVD morbidity and mortality associated with
hypertension in the United States. Systems theory provides the organizing theoretical
framework through which the indicators at different levels and of different domains can
be explicitly integrated dynamically in understanding health disparities (Diez Roux,
2011). Additionally, Systems theory allows the synthesis of meaning from a broad
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evidence base by simultaneously exploring relationships among different subareas (i.e.,
health disparities indicators, hypertension and cardiovascular disease) of the field being
considered (Mabry, 2010). Systems theory was utilizes for this study’s macro level focus
on hypertension and cardiovascular disease across the United States by providing
national level health disparities data and addressing the social determinants of health.
Literature Review Related to Key Variables and Concepts
Morbidity and Mortality of Cardiovascular Diseases and Hypertension
There are numerous studies that highlight the impact of hypertension on certain
subpopulations. I utilized the research questions to examine whether significant
differences exist in the selected CVD morbidity and mortality outcomes between
hypertensive subpopulations who are experiencing health disparities among people with
hypertension when three or more indicators (race, gender, education, income) intersect. I
reviewed the literature related to the research questions. For example, in a research study
by Loustalot, et al. (2014), the researchers examined the trends in mortality by subtypes
of heart disease in the United States. Loustalot, et al. (2014) found that mortality rates
for hypertensive heart disease among Blacks were significantly higher than Whites in
2010 (50.9 per 100,000). The Framingham Study is a sentinel study in this literature
review. It was the first major observational study that included substantial numbers of
women and it has been central to the development of the notion of absolute risk and the
importance of hypertension alongside other risk factors (Turnbull, 2010). Much of our
current understanding of the role blood pressure in cardiovascular disease can be
attributed to the research from Framingham.
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Hypertension
I reviewed the literature for hypertension and its relationship to CVD morbidity
and mortality. Hypertension impacts approximately 1 in 3 adults (an estimated 75
million) in the United States (Fryar, et al., 2017). I also reviewed hhypertension health
disparities. In a study by CDC (2005), the researchers analyzed self-reported data from
the 2003 BRFSS survey. The CDC (2005) researchers examined six risk factors for heart
disease and stroke: high blood pressure, high cholesterol, diabetes, current smoking,
physical inactivity, and obesity. In this study, 37.2% of respondents reported having two
or more of the six heart disease and stroke risk factors examined (CDC, 2005). The CDC
study is similar to this research study in its examination of multiple risk factors for CVD.
However, to expand on the prior study, I analyzed the potential relationship between
health disparity indicators and CVD.
I reviewed the literature that specifically identified racial disparities in
hypertension. Hypertension is a major cause of disparities in mortality between Blacks
and Whites in America because of the differences in prevalence and in hypertension
control (Satcher, 2008; Opara, et al., 2013). In another study, racial disparities in systolic
blood pressure (SBP) measurements were analyzed among 1,545 Black adults and 1,335
White adults (Fiscella & Holt, 2008). The results of the study showed that the mean SBP
among Blacks with hypertension was approximately 6 mm Hg higher than that for the
total adult Black population and 7 mm Hg higher than that for Whites with hypertension.
In addition to race, I identified other indicators (i.e., gender, education, income,
and geographic location) that are linked to disparities in hypertension and evaluated in
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the literature. For example, in one cohort study, the researchers sought to examine the
change in the all-cause mortality rate among people with and without hypertension in the
United States and whether any such changes differed by sex or race (Ford, 2011). The
researcher found that the mortality rate was higher among hypertensive adults than nonhypertensive adults, among hypertensive men than hypertensive women, and among
hypertensive Blacks than hypertensive Whites (Ford, 2011). I determined the prevalence
of healthy diets in overweight U.S. adults by race or ethnicity by using dietary recalls
from the National Health and Nutrition Examination Survey of 1999 to 2000. After
controlling for dietary factors, Black ethnicity was associated with a greater risk of high
SBP compared to Whites (Diaz, et al., 2005). This is an example of a national study that
focuses on racial health disparities in hypertension. However, in this study I go further
by examining the cumulative effect of multiple health disparity indicators among people
with hypertension.
Impact of Geographic Location on CVD and Hypertension
I reviewed the morbidity and mortality outcomes for CVD and hypertension by
geographic location in the scientific literature. A critical review of the literature revealed
that there are certain areas in the United States that are more heavily impacted by health
disparities than others. Cosby and Bowser (2008) described the disparities associated
with excess mortality in the Delta region of the United States The Delta region refers to
the 252 economically distressed counties in the following eight states: Alabama,
Arkansas, Illinois, Kentucky, Louisiana, Mississippi, Missouri, and Tennessee (National
Park Service, 2001). Cosby and Bowser (2008) found that mortality disparities in the
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Delta had doubled to about 187 excess deaths per 100,000, or approximately 18,000
excess deaths in 2004. Cosby and Bowser (2008) concluded that these deaths would not
have occurred had the region achieved the average rate of mortality experienced by the
remainder of the nation.
Geographic location has been shown to play a factor in health outcomes related to
heart disease and hypertension. Schieb, et al. (2013) examined National Vital Statistics
mortality data from 2001-2010 by race and gender in geographic regions of the United
States The emphasis of the researchers was primarily on geographic regions, race and
gender. Schieb, et al. (2013) found that CVD mortality was disproportionately
impacting Blacks and is located in the southern region of the United States. Regarding
gender, Black men experienced the most CVD deaths. However, they did not include
education and income as focus areas.
In a study that relied on data from the BRFSS and the American Community
Survey, Jones (2013) examined the impact of segregation and socioeconomic status
(SES) on hypertension for a sample of 200,102 individuals (Jones, 2013). Jones (2013)
analyses and findings revealed that both segregation and hypersegregation (i.e., areas
where there is very little interaction with non-Black residents) were associated with
hypertension. However, highly educated and high-earning individuals were protected
against hypertension in both segregated and hypersegregated environments (Jones, 2013).
I compared rural and urban incidence of coronary heart disease. O’Connor and
Wellenius (2012) examined the rural-urban differences in the prevalence of diabetes and
coronary heart disease, and the extent to which they are explained by the presence of
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established risk factors including poverty. The crude prevalence rates of coronary heart
disease was 38.8% (P < 0.001) higher among respondents living in rural areas compared
with urban areas (O’Connor & Wellenius, 2012). After controlling for poverty, obesity,
tobacco, and other risk factors, the prevalence of coronary heart disease was higher
among respondents living in rural areas (O’Connor & Wellenius, 2012). This research
study expanded this area of research by using national data to analyze health disparity
indicators in people with hypertension across regions and states of the U.S.
Impact of Race on CVD and Hypertension
CVD and race. Race has also been found to play a major role as a CVD risk
factor among certain subpopulations. For example, Liu, et al., (2011) investigated racial
disparities and trends in glycosylated hemoglobin, high-density lipoprotein (HDL), Creactive protein, plasma homocysteine, albuminuria, and other risk factors among 4,758
diagnosed hypertensive subjects age 18 years or older from the NHANES, 1999-2006.
They found that Hispanics, and non-Hispanic Blacks were more likely to have
uncontrolled blood pressure (BP) (Hispanics odds ratio [OR]: 1.58, 95% confidence
interval [CI]: 1.21-2.07; Blacks OR: 1.42, 95% CI: 0.21-1.67), elevated glycosylated
hemoglobin (Hispanics OR: 2.70, 95% CI: 1.89-3.87; Blacks OR: 2.17, 95% CI: 1.702.77), albuminuria (Hispanics OR: 2.36, 95% CI: 1.71-3.27; Blacks OR: 1.80, 95% CI:
1.47-2.20), and less likely to have central obesity (Hispanics OR: 0.68, 95% CI: 0.510.91; Blacks OR: 0.70, 95% CI: 0.58-0.84). Blacks had lower risks of elevated serum
cholesterol (OR: 0.81, 95% CI: 0.67-0.98) and low HDL (OR: 0.76, 95% CI: 0.61-0.94)
than Whites. The risk of high serum homocysteine was lower in Hispanics and higher in
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Blacks compared with Whites (Hispanics OR: 0.64, 95% CI: 0.46-0.90; Blacks OR: 1.36,
95% CI: 1.14-1.63). These findings are in alignment with other studies of this type that
were reviewed.
A study by Holm, et al., (2010) measured health disparities by comparing the
American Indian sample data with a northern plains statewide (North Dakota) sample and
a United States national sample. Holm, et al., (2010) compared outcomes with BRFSS
statewide (North Dakota) and U.S. national data from telephone-based interviews. The
American Indian participants showed a significantly greater coronary heart disease than
either the regional or national samples (Holm, et al., 2010). They also reported being less
likely to engage in leisure-time physical activity and to have had age-appropriate
preventive screenings for several diseases including colorectal cancer, prostate cancer,
breast cancer, and cardiovascular disease.
Hypertension and race. Race is a known population parameter and health
indicator that is commonly associated with health disparities that has been studied in
numerous creative ways. A sentinel study of racial discrimination examined the
relationships between blood pressure and self-reported experiences of racial
discrimination and responses to unfair treatment (Kreiger & Sidney, 1996). The
researchers found that Black-White differences in blood pressure were substantially
reduced by taking into account reported experiences of racial discrimination and
responses to unfair treatment (Krieger & Sidney, 1996).
Race can also play a factor in patient satisfaction. The researchers in this study
compared the determinants of satisfaction with medical care among 1,784 (781 Black and
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1,003 Caucasian) cardiac patients (LaVeist, et al., 2000). They found that the perception
of racism and mistrust of the medical care system led to less satisfaction with care among
Blacks (LaVeist, et al., 2000). In a study that analyzed temporal trends in population
attributable risk for CVD, the researchers studied 13,541 participants (56% women, 26%
Black) in the Atherosclerosis Risk in Communities Study, aged 52 to 66 years and free of
CVD at exams in 1987 through 1989, 1990 through 1992, 1993 through 1995, or 1996
through 1998 (Cheng, et al., 2014). It was determined from this study that the
contribution to CVD of all traditional risk factors combined is greater in Blacks than
Whites, and the contributions of hypertension remain especially high, in women as well
as Blacks (Cheng, et al., 2014).
This research study seeks to examine race by taking a national perspective and
examining the cumulative effect of risk factors that are associated with CVD and
hypertension health disparities. Similar studies have been done which have analyzed
national data and found health disparities. An example of a study that spanned across 17
states and 28 communities reinforces the need to further examine health disparities data
from a national perspective. In this study, Liao, et al. (2011) utilized data from the
REACH U.S. Risk Factor Survey to demonstrate that residents in most of the minority
communities continue to have lower socioeconomic status, greater barriers to health-care
access, and greater risks for and burden of disease compared with the general populations
living in the same MMSA, county, or state. However, there are fewer studies that have
analyzed the cumulative effect of racial health disparities indicators among people with
hypertension and CVD.
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In addition to Blacks and Hispanics, American Indian/Alaska Natives were also
found to experience disparities in blood pressure when compared to Whites. Amparo, et
al., (2011) examined the prevalence of high cholesterol, high blood pressure, diabetes,
body mass index data for 2,821 American Indian/Alaska Native women and 105,664 nonHispanic White women aged 18 to 44 years from the 2005 and 2007 Behavioral Risk
Factor Surveillance System. American Indian/Alaska Native women were found to have
significantly higher rates of high blood pressure (Amparo, et al., 2011).
There were studies identified that examined the intersection of race with other
indicators of hypertension and CVD. In one such study, the researchers evaluated the
disparate association of BMI and risk of hypertension and diabetes in Asians in a
retrospective study of 150,753 adults from the 1985-2011 California Behavioral Risk
Factor Survey (Wong, et al., 2014). Asians had the lowest BMI among all groups.
However, the impact of increasing BMI on risk of hypertension and diabetes was
significantly greater in Asians (Wong, et al., 2014). To examine racial/ethnic disparities
in awareness, treatment, and control of high blood pressure by hypertension stages, the
Centers for Disease Control and Prevention (2013) analyzed data from the National
Health and Nutrition Examination Survey (NHANES) for the period 2003-2010. The
researchers found that the proportion of Mexican-Americans and Blacks with stage 1 and
stage 2 hypertension was greater than for Whites (Centers for Disease Control and
Prevention, 2013).
A study by Zhang and Rodriguez (2012) investigated racial/ethnic disparities in
the prevalence of obesity and its related diseases in Massachusetts and assess disparities
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in the risk of developing diseases related to overweight and obesity. Hypertension and
CVD are obesity-related diseases that were included in the outcome measures. Blacks
had higher odds of high blood pressure (OR = 1.88), heart attack (OR = 1.40) and stroke
(OR = 2.14) than Whites. Hispanics were more likely to have high blood pressure (OR =
1.34), high cholesterol (OR = 1.56), stroke (OR = 1.71), and heart attack (OR = 1.54)
than Whites (Zhang & Rodriguez, 2012). Health behaviors and disparities in blood
pressure control were examined by race in a study using data from the NHANES in
another study. Data from NHANES were analyzed to conduct cross-sectional analyses
among 21,489 U.S. adults aged >20 years participating in NHANES from 2001 to 2006
(Redmond, et al., 2011). Non-Hispanic Blacks were found to have 90% higher odds of
poorly controlled blood pressure compared with non-Hispanic Whites after adjustment
for sociodemographic and clinical characteristics (P<0.001) in primary analyses. In
secondary analyses among hypertensive subjects, non-Hispanic Blacks and Mexican
Americans had 40% higher odds of uncontrolled blood pressure compared with nonHispanic Whites after adjustment for sociodemographic and clinical characteristics
(P<0.001). Additionally, for both analyses, the racial/ethnic differences in blood pressure
control persisted even after further adjustment for modifiable health behaviors, which
included medication adherence in secondary analyses (P<0.001 for both analyses)
(Redmond, et al., 2011). A cross-sectional study was conducted to determine whether
being Black and having poor BP control interact to adversely affect patient-physician
communication more than either condition alone. This situation is referred to as "double
jeopardy” by Cene, et al., (2009). After controlling for patient and physician
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characteristics, the researchers found that Blacks with uncontrolled BP have shorter visits
with less biomedical, psychosocial, and rapport-building statements than Whites with
controlled BP (Cene, et al., 2009). A large amount of research has been done that
demonstrates the impact of race on hypertension and CVD. This research study goes
further by linking race to other health disparity indicators to analyze their effect on CVD
and hypertension.
Impact of Age on CVD and Hypertension
The literature was reviewed to investigate the impact of age as a risk factor for
CVD and hypertension. A study by Gupta (2014) analyzed multiple risk factors as well
as self-reported CVD prevalence overall and discuss differences in prevalence by age.
Analysis was conducted using Delaware data for 4,777 respondents from the 2011
BRFSS. Overall, 22.51% of persons reported having no risk factors, 32.30% reported
one risk factor, and 45.20% reported multiple risk factors and prevalence of multiple risk
factors was higher for the aged, less educated, and unemployed (Gupta, 2014).
Age was found to be related to pre-hypertension in a study by Glasser, et al.,
(2011). They conducted a cross-sectional analysis of 5,553 pre-hypertensives, 20,351
people with hypertension, and 4,246 non-hypertensive participants (age >45 years) from
the REasons for Geographic And Racial Differences in Stroke Study (REGARDS) data to
determine racial, clinical, and demographic differences in the prevalence of prehypertension and its cross-sectional association with vascular risk factors. The
prevalence of pre-hypertension increased by age and African-American race (Glasser et
al., 2011).
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The notion that in persons of older age, SBP is no longer associated with
mortality was examined in the Rotterdam Study. The Rotterdam Study is a populationbased prospective cohort study among 4,612 participants aged >55 years without
previous cardiovascular disease and with a median follow-up of 14.9 (interquartile range,
11.1-15.8) years (Blom, et al., 2013). Analyses in the 5-year age groups revealed an
increased risk with higher SBPs up to age 75 years, and after 75 years, a trend towards
systolic blood pressure no longer being associated with an increased mortality risk was
seen in the study (Blom, et al., 2013).
Role of Gender in CVD and Hypertension Health Outcomes
CVD are the main cause of death in women and men worldwide (Hochleitner,
2013). According to Hochleitner (2013) Gender Medicine research has shown gender
differences in cardiology to the detriment of women, for example it takes longer for them
to receive and they are less likely to have access to high-tech medicine, such as the ICU,
heart catheters, bypass surgery, and they have poorer outcomes (Hochleitner, 2013).
Many research studies were found that examined gender in relation to hypertension and
CVD health outcomes. A specific focus was placed on the comparison of women by race
and/or ethnicity in many of the articles that were reviewed. For example, a review of the
recent literature on the subject of CVD in women over the past several years was
conducted with an emphasis on CVD in Black women and Caucasian women (Williams,
2009). According to Williams (2009), the mortality rate from coronary artery disease is
69% higher in Black women than in Caucasian women. Mortality for Black females was
also found to be much higher (352%) from hypertension than for White females.
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Hypertension and the specified cardiovascular events in this study that was conducted,
compared male and female genders with each other, as well as with the other indicators.
Gender was linked to other risk factors in the literature that was reviewed.
Andersen and Jensen (2013) conducted a longitudinal study (i.e., the Copenhagen City
Heart Study) of the association between income factors and trends in population blood
pressure and hypertension. This Copenhagen City Heart Study is a prospective
longitudinal epidemiological study on almost 20,000 individuals through four surveys
from 1976 to 2003. After adjusting for cardiovascular risk factors, there were no
significant differences in systolic blood pressure trends associated with income among
men. Among women, however, there was a reverse relationship between SBP and
income. In addition, there was a trend towards a lowering of risk-factor adjusted SBP in
the high income women with time (Andersen & Jensen, 2013).
Community-based CVD programs that are tailored to reach women are needed.
Altman et al., (2014) utilized a systems approach to develop, assess, and pilot a
community-based education program for improving outcomes for knowledge/awareness
of CVD, cardiometabolic risk, and health behaviors in Latinas. It was determined that a
bilingual culturally appropriate community-based CVD-prevention program based on
health education, medical screenings, and empowerment is a successful, effective,
adaptable, and replicable model to significantly improve cardiometabolic risk in Latinas
(Altman et al., 2014).
CVD mortality was analyzed by gender in three different regions (27 countries)
in a time series study of the Americas by Gawryszewski and Souza (2014). During the
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study period, the age-adjusted mortality rates for men were higher than those of females
in all regions and North America showed lower rates than Latin America countries and
the Non-Latin Caribbean (Gawryszewski & Souza, 2014). A similar investigation in the
U.S of gender along with other risk factors for CVD is much needed.
Andersen and Jensen (2013) investigated the association between income factors
and trends in population BP and hypertension in the prospective longitudinal Copenhagen
City Heart Study among women. They found that women in higher income groups have
lower systolic blood pressure than women in low-income groups and the gap between
SBP in high-income women and low-income women increased with time. There were no
significant differences in SBP-trend associated to income among men (Andersen &
Jensen, 2013).
When gender is associated with race, Blacks continue to be the most
disproportionately impacted. Black women were compared to Caucasian women in
regards to 4 categories of CVD: coronary artery disease (CAD), hypertension, stroke, and
congestive heart failure (CHF) in a literature review (Williams, 2009). The statistical
findings from Williams’ (2009) review of the research over the past several years indicate
that Black women have greater mortality than Caucasian women from CAD,
hypertension, stroke, and CHF. Incidence, prevalence, and morbidity figures for CAD,
hypertension, stroke, and CHF are all higher for Black females than for Caucasian
females (Williams, 2009).
Role of Education in CVD and Hypertension Health Outcomes

40
There has been a long-standing inverse relationship between education and
mortality that has strengthened substantially at the end of the 20th century (Cutler, et al.,
2011). For example, during 1986 to 2002, the growing gradient for all-cause mortality
reflected increasing mortality among low-educated women and declining mortality
among college-educated women; during 2003 to 2006 it mainly reflected declining
mortality among college-educated women (Montez & Zajacova, 2013).
The need to understand the relationship of educational achievement with
hypertension and CVD morbidity and mortality outcomes is important. This is important
because educational achievement has been negatively linked to numerous other health
conditions and health outcomes (Cutler, 2011). An example of a publication that used
national data to study education was identified. A cross sectional study using the 2006
Behavioral Risk Factor Surveillance System (BRFSS) was conducted (Kelly & Weitzen,
2010). Among respondents aged 40 years and older to the 2006 BRFSS survey those
with less than a high school education had 3.09 (95% CI: 2.79-3.43) times the odds of
having had a myocardial infarction (MI) compared to college graduates. After adjusting
for confounders, respondents with less than a high school education had 1.61 (95% CI:
1.41-1.83) times the odds of having had an MI compared to college graduates.
According to the researchers’ findings, participants with a high school education and
those who completed some college or technical school were 1.22 times more likely to
have had a myocardial infarction in comparison to college graduates (Kelly & Weitzen,
2010).
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Education was often studied in conjunction with other indicators. For example,
Gupta (2014) examined the disparities associated with the risk factors for CVD in
Delaware. In the manuscript, the researcher stated that prevalence of multiple risk factors
was higher for the aged, less educated, and unemployed. This study, as well as many
others that were reviewed, focused on state-level data.
Impact of Income on CVD and Hypertension Health Outcomes
Income levels can be linked to the health outcomes of many diseases and
conditions. The relationships between income and hypertension, as well as CVD, were
reviewed in the literature. A good example is found in a study that was done to assess
whether community affluence modifies the association between individual SES and six
CVD risk factors: diabetes, hypertension, physical inactivity, obesity, smoking, and poor
nutrition (Abeyta, et al., 2012). Data were stratified from the Colorado Behavioral Risk
Factor Surveillance System for 2007 and 2008 based on individual socioeconomic status
and three categories of community affluence (median household income of county).
People who had a low SES seemed to benefit from residing in high-affluence
communities. Living in high-affluence communities may counteract the effect of poverty
on CVD risk factors. Findings such as these support the value of interventions that
address the social determinants of health (Abeyta, et al., 2012).
Income studies have been done in other countries. One such study examined
hypertension screening campaigns in middle-income countries. The researchers sought
to identify socio-demographic predictors of hypertension prevalence, diagnosis,
treatment, and control among 6 middle-income countries (China, Ghana, India, Mexico,
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Russia, and South Africa) (Basu & Millet, 2013). Insurance status and income were
found to be significant correlates to diagnosis and treatment probability (Basu & Millet,
2013).
The ability to obtain health insurance in the United Stares is more commonly
linked to one’s ability to have a source of employment that provides health care coverage.
Brooks, et al., (2010) investigated the relations of health insurance status to the
prevalence, treatment, and control of major cardiovascular disease risk factorshypertension and elevated low-density lipoprotein (LDL) cholesterol-among Framingham
Heart Study (FHS) participants in gender-specific, age-adjusted analyses among 6098
participants. At the time of the FHS clinic examination, 3.8% were uninsured and ages
ranged from 19 to 64 years. The researchers concluded that treatment and control of
hypertension and hypercholesterolemia were lower among uninsured adults (Brooks, et
al., 2010). Specifically, they found that: 1) the prevalence of hypertension and elevated
LDL cholesterol was similar for the insured and uninsured; 2) the proportion of those
who obtained treatment and achieved control of these risk factors was lower among the
uninsured; and 3) uninsured men and women were less likely to be treated for
hypertension (Brooks, et al., 2010).
Hajat, et al., (2010) examined the relationship between wealth and three CVD risk
factors (smoking, obesity and hypertension) in a U.S. population from the Panel Study of
Income Dynamics (PSID) collected between 1999 and 2005. They defined wealth as
inflation-adjusted net worth and specified as a six category variable: one category for
those with less than or equal to zero wealth and quintiles of positive wealth. A weak
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inverse association between wealth and hypertension incidence was found after
controlling for income and other time-varying confounders (Hajat, et al., 2010).
Research has been done on an aggregate basis across multiple countries on
various income levels. One study sought to identify sociodemographic predictors of
hypertension prevalence, diagnosis, treatment, and control among middle-income
countries. The researchers analyzed data from 47,443 adults in 6 middle-income
countries (China, Ghana, India, Mexico, Russia, and South Africa) sampled in nationally
representative household assessments from 2007 to 2010 as part of the World Health
Organization Study on Global Aging and Adult Health (Basu & Millett, 2013).
Hypertension prevalence varied from 23% (India) to 52% (Russia), with between 30%
(Russia) and 83% (Ghana) of people with hypertension undiagnosed before the survey
and between 35% (Russia) and 87% (Ghana) untreated (Basu & Millett, 2013).
Additionally, Basu and Millett (2013) found that insurance status and income emerged as
significant correlates to hypertension diagnosis and treatment probability.
Implications of Past Research on Present Research
The literature was reviewed and the findings indicate that much research has been
conducted on CVD and hypertension morbidity and mortality in general. Sentinel studies
such as the Framingham Study (Lalonde, 2012; Turnbull, 2010) and the CDC article
titled: Trends in Mortality Rates by Subtypes of Heart Disease in the United States, 20002010 by Ritchey, et al., (2014) have established the foundation for this literature review.
Subpopulations who are disproportionately impacted by morbidity and mortality
indicators that are linked to CVD and hypertension were identified and analyzed in the
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literature. The findings from this literature and research will contribute to achieving
health equity by addressing the health disparities in CVD and hypertension among those
subpopulations who are disproportionately impacted. According to the World Health
Organization, health equity is “the absence of unfair, avoidable or preventable differences
in health among populations or groups defined socially, economically, demographically
or geographically” (World Health Organization, 2015, Paragraph 27).
The CVD of focus include stroke, hypertensive disease, and chronic rheumatic
heart disease. The impact of CVD on hypertensive populations was established based on
the past research. There were specific subpopulations who were the most impacted when
the indicators were also examined (Ritchey, et al., 2014; Satcher, 2008; Ford, 2011).
These subpopulations included Blacks, low income groups and people with low
educational attainment. Additionally, there were few research studies found that
examined CVD and hypertension on the national level. These studies examined some of
the indicators also (Liao, et al., 2012; Ritchey et al., 2014). However, there were no
recent studies that examined the cumulative effect of three or more health disparities
indicators of CVD in hypertension on a national level.
Summary
Each of the indicators (i.e., race, gender, education, income, age, and geographic
location) was examined in relation to CVD and hypertension in this literature review.
The availability of literature varied from a very large amount for race to a very small
number of relevant articles for geographic location. Morbidity and mortality health
disparities were found to exist for CVD and hypertension for the indicators in certain
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subpopulations. In many instances, indicators were found to overlap in some
subpopulations. For example, race: Black, gender: female, and low income were linked
to CVD (Williams, 2009; and O’Connor & Wellenius, 2012). The cumulative effect of
the indicators for CVD among hypertensive persons across the United States is of
particular concern in this literature review. Very few studies of this type were found.
Although some preliminary research on states and communities explore the cumulative
effect of the indicators for CVD among hypertensive persons, what has yet to be
established in the literature are the impact of numerous indicators for CVD morbidity and
mortality intersecting among people with hypertension in a national representative
sample.
The design for this study was chosen based upon a careful review of existing
public health literature in the areas of surveillance research associated with CVD,
hypertension, health disparities in CVD and hypertension, and the indicators for
morbidity and mortality. Numerous state- and local-level research studies were found that
examined the prevalence of cardiovascular diseases, as well as hypertension, and the
associated risk factors on the state and local levels. On the other hand, few studies were
found that applied a health equity lens to national hypertension data and compared it with
cardiovascular morbidity and mortality data across the geographic regions of the United
States. This study utilized national level data to analyze the cumulative effect of health
disparity indicators on CVD morbidity and mortality among people with hypertension.
The gaps in the literature that were described are addressed in the methods
described in Chapter 3 of this study. In Chapter 3, the cumulative effect of indicators
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(i.e., race, gender, education, income, and geographic location) among individuals within
certain subpopulations will be examined to determine whether or not there are significant
differences in CVD morbidity and mortality outcomes among hypertensive
subpopulations experiencing health disparities.

Chapter 3: Research Method
Purpose of the Study
The purpose of this study was to examine the cumulative effect of demographic
characteristics (i.e., race, gender, education, and income) on CVD health outcomes (i.e.,
coronary heart disease) among hypertensive subpopulations. Surveillance data from
across the United States between 1999 to 2010 was used to determine if there are
significant differences in CVD morbidity and mortality outcomes among hypertensive
subpopulations that are linked to CVD and hypertension health disparities. I selected the
years of 1999 to 2010 because they were the most recent data available that included the
variables of interest. Numerous studies have been conducted that link one or two (i.e.,
race and/or gender) indicators for health disparities to CVD morbidity and/or mortality
(Loustalot, et al., 2014; Turnbull, 2010). However, more research is needed to examine
whether there are differences in health outcomes among subpopulations with
hypertension who have numerous indicators for health disparities in comparison to
subpopulations with hypertension who have one or fewer health disparities indicators. In
this study I explored this potential association between numerous demographic
characteristics among persons with hypertension and/or CVD outcomes.
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This chapter contains a description of the study’s design, sample, instrumentation,
data analysis, and ethical considerations. An overview of the study’s design includes a
rationale for why I selected this specific research design. I presented the sample
characteristics and size as well as a description of the instrumentation. I also discussed
the data collection process and analysis.
Research Design and Rationale
I utilized the quantitative cross-sectional observational study design for this study.
Study Variables
Dependent variable. The dependent variables were blood pressure readings,
being told that you had high blood pressure as well as CVD morbidity and mortality
variables from the National Health and Nutrition Examination Survey (NHANES). I
extracted other variables related to CVD morbidity and CVD mortality data variables
(i.e., coronary heart disease, acute myocardial infarction, and cardiac dysrhythmia from
International Classification of Diseases, 9th and 10th Revision (ICD-9 and 10 Codes)
codes of the National Death Index (NDI) survey.
Independent variable. Independent variables were hypertension, education
level, household income, race/ethnicity, body mass index (BMI), and gender. I obtained
each of the independent variables from NHANES. Hypertension is defined as 140
mmHg or higher systolic, and/or 90 mmHg or higher diastolic (U.S. Preventive Services
Task Force, 2007).
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Research Design
In this cross-sectional observational study, I analyzed multiple demographic
characteristics (i.e., indicators for health disparities) and generalized from large samples
to the United States population. The cross-sectional observational study was appropriate
because it provides a numeric description of the relevant trends of certain subpopulations
in the United States (Creswell, 2009). The cross-sectional observation study is less
expensive and time consuming than a longitudinal study. Specifically, I utilized
secondary data analysis on previously collected data to explore potential differences in
health outcomes among subpopulations with hypertension who have varying indicators
for health disparities, as well as address the research questions by studying a sample of
that population. The population and sample data from the cross-sectional study is
collected at one specific point in time versus a period of time. This has assisted me in
completing the study within a reasonable period of time. I utilized this research design to
address the research questions and the purpose by allowing multivariate analyses,
absolute, and relative risks to be calculated from the prevalence of CVD morbidity and
mortality between hypertensive subpopulations.
Methodology
Study Population
The population of this study consists of the participants who were screened,
interviewed, and examined between 1999 to 2010 in alignment with the data that are
available from the National Death Index. The information gathered by NHANES
provides a glimpse of the health and nutrition for a broad range of age groups as well as
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racial/ethnic characteristics of the United States population (Centers for Disease Control
and Prevention, 2015). The study participants are found in 15 randomly selected counties
across the United States.
Study Sample
Inclusion criteria. For this research study, the sample consists of persons
identified in NHANES data between the years of 1999-2010. I calculated the rates of
hypertension for various subgroups. In addition, I conducted analyses on the persons
with hypertension who are 30 years and older. I selected this age range because it
represents the majority of the adult population who are most vulnerable to hypertension
and CVD (Centers for Disease Control & Prevention, 2015). The sample with
hypertension was defined by persons who answered yes to at least one of the following:
ever told that they had high blood pressure (blood pressure readings which are at least
140 millimeters of Mercury (mmHg) systolic and/or at least 90 mmHg diastolic); told
had high blood pressure two or more times; or taking prescriptions for hypertension.
Exclusion criteria. I excluded persons who are under the age of 30 years old
from the study. Additionally, I excluded persons with blood pressure readings of less than
140 mmHg systolic and less than 90 mmHg diastolic that were taken during the physical
examination and who are not taking prescriptions for hypertension from the study.
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Power Analysis
This is a cross-sectional study in which I utilized secondary data from a large
publicly available and nationally representative data set. For this study, I computed a
priori power analysis to establish the required sample size, given Alpha (α), power, and
effect size. I assumed a small effect size of 0.25, along with a power of 0.80 (1-β error
probability) and alpha of error probability of 0.05. The resulting sample size was 95 total
participants for both research questions using multiple regression statistical tests of four
variables. The large sample size (at least 1,000 participants) in this study exceeds the
power needed. A statistical program such as G*Power can be used to determine the
appropriate study sample size. G*Power is designed to be a stand-alone power analysis
program for statistical testing (Kraemer & Thiemann, 1987).
Procedures for Recruitment, Participation, and Data Collection
The NHANES survey conducted by the CDC is the original study and it served as
the data source for this study (CDC, 2015). Population data were collected on the
prevalence of chronic conditions such as hypertension and diabetes. Personal interviews,
physical examinations, laboratory tests, nutritional assessments, and a DNA repository
are the primary data sources and methods of NHANES. The home interview and the
physical examination were the two main sources of data for this study.
NHANES home interview. The NHANES home interview consisted of
demographic, socioeconomic, dietary, and health-related questions. The interviewer only
interviewed those individuals who were at least 18 years-old. During the home
interview, participants were asked questions about their health, disease history, and diet.
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There were questions that were relevant to my research study. The questionnaire was
retrospective, and I placed a particular interest on the questions that focus on
hypertension and CVD. I extracted the participants’ responses to these questions.
Physical examination. The physical examination consisted of a number of
measurements and tests that are contingent upon the age, gender and self-reported
medical conditions of the participants. Medical, dental, and physiological measurements,
and laboratory tests make up the physical examination portion of NHANES (CDC, 2015).
I analyzed the participants’ blood pressure readings from the physical examination.
Procedures for Recruitment. The following procedures for recruitment were
used in the original NHANES study. The communities and participants within those
communities were selected using a complex, multistage probability sampling design
(CDC, 2013). The researchers divided the United States into communities that were
subdivided into randomly selected neighborhoods. From each neighborhood, housing
units were selected at random. Selected households were approached by the NHANES
interviewers who asked residents a few short questions to determine if individuals in the
household were eligible. A computer algorithm randomly selects all, some, or none of
the members of the household. According to the CDC (2015), approximately 5,000
persons are selected each year in 15 counties representing around 50,000 other U.S.
residents. Persons 60 years-old and up, Blacks, and Hispanics are oversampled to
increase the reliability and precision of estimates of health status indicators for these
population subgroups (CDC, 2015). The identities of the participants are held strictly
confidential. NHANES is a publicly accessible database and access and necessary
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permission to restricted data items in the data set are gained by submitting a proposal to
the Research Data Centers at the NCHS. The information needed for this research study
can be obtained from the publicly available data sets.

Instrumentation
The United States Department of Health and Human Services created the National
Center for Health Statistics (NCHS) in 1959. The NCHS is an agency at the who
manages NHANES and the Behavioral Risk Factor Surveillance System (BRFSS). In
addition, NCHS extracts mortality data files from the National Death Index (NDI) survey
and links that data to NHANES. NHANES has undergone revisions and updates
throughout the years. The current version of NHANES began in 1999 (CDC, 2013).
Health interviews were used to collect the data at the participants’ homes and from
mobile examination centers. These are highly equipped medical vans that are driven by
the NHANES examiners. The health interviews consisted of home interviews and the
physical examinations of the selected participants followed by laboratory testing.
According to the CDC (2013), the oversampling of the participants that was previously
mentioned helps to increase the reliability and precision of the health status indicators for
the selected population subgroups.
The information, such as the blood pressure and cardiovascular disease questions,
which is collected from the health interviews are closely related to the variables of
interest in the current study. The demographic, hypertension, and CVD variables from
the current study can be identified in the home interviews and physical examinations.
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Demographic variables that were collected from NHANES participants during the home
interviews include: race, gender, age, education and income. The demographic
characteristics were used as composite variables and compared based on the relevant
CVD and hypertension variables from NHANES. Variable scores for the demographic
characteristics were developed based on the level of risk for CVD mortality and
morbidity. For example, the variable scores for race were determined for Blacks, Whites,
Asians, Hispanics and others. The subpopulation with the highest risk for CVD mortality
received a score of 5 followed in descending order by the other racial groups. Frequency
distributions of scores from high to low risks were developed. The following CVD and
hypertension variables with their descriptions were retrieved from NHANES. They were
helpful in answering the research questions.
Operationalization of the Variables
The operational definitions of education level, household income, race/ethnicity,
and gender can be found in the variable tables below. Control variables are taking
hypertension medications, taking cardiovascular medications, smoking, and
cardiovascular fitness.
NHANES Variables
The following tables contain descriptions of the demographic, dependent, and
outcome variables for education level, gender, age, race/ethnicity, household income,
hypertension, Body Mass Income, Hypertension and CVD treatments and
conditions/symptoms.
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Demographic Variables:
Table 1
Highest Education Level Achieved by Adults
Code or Value

Value Description (Ordinal level of measurement)

1

Less Than 9th Grade

2

9-11th Grade (Includes 12th grade with no diploma)

3

High School Grad/GED or Equivalent

4

Some College or AA degree

5

College Graduate or above

7

Refused

9

Don't Know

.

Missing

Table 2
Gender of Participants
Code or Value

Value Description (Nominal level of meas.)

1

Male

2

Female

Table 3
Age of Participants at Screening
Code or Value

Value Description (Ordinal level of meas.)

0 to 84

Range of Values

85

>= 85 years of age
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Table 4
Race/Ethnicity of Participants
Code or Value

Value Description (Nominal level of meas.)

1

Non-Hispanic White

2

Non-Hispanic Black

3

Mexican American

4

Other Race - Including Multi-Racial

5

Other Hispanic

Table 5
Annual Household Income of Participants
Code or Value

Value Description (Nominal level of meas.)

1

$ 0 to $ 4,999

2

$ 5,000 to $ 9,999

3

$10,000 to $14,999

4

$15,000 to $19,999

5

$20,000 to $24,999

6

$25,000 to $34,999

7

$35,000 to $44,999

8

$45,000 to $54,999

9

$55,000 to $64,999

10

$65,000 to $74,999

11

$75,000 and Over

12

Over $20,000

13

Under $20,000

Table 6
Body Mass Index (BMI) of Participants
Both males and females 2yrs. – 150 yrs.
Code or Value

Value Description

12.1 to 82.9

Body Mass Index (kg/m**2)
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Dependent and Outcome Variables:
Table 7
Hypertension Variables
Variable
Name

BPQ020

BPQ030

BPQ040A

SAS Label

Variable Description

Ever told you had high
blood pressure

{Have you/Has} ever
been told by a doctor
or other health
professional that
{you/s/he} had
hypertension, also
called high blood
pressure?

Told had high blood
pressure - 2+ times

{Were you/Was} told
on 2 or more different
visits that {you/s/he}
had hypertension, also
called high blood
pressure?

Taking prescription for
hypertension

Because of (high blood
pressure/hypertension),
{have you/has s/he}
ever been told to . . .
take prescribed
medicine?

Systolic: Blood pressure
BPXSY1

BPX_H
(first reading) mm Hg

Diastolic: Blood pressure
BPXDI1

BPX_H
(first reading) mm Hg

Systolic: Blood pressure
BPXSY2

BPX_H
(second reading) mm Hg

Diastolic: Blood pressure
BPXDI2
(second reading) mm Hg
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Systolic: Blood pressure
BPXSY3

BPX_H
(third reading) mm Hg

Diastolic: Blood pressure
BPXDI3
(third reading) mm Hg

Systolic: Blood pressure
BPXSY4

BPX_H
(fourth reading) mm Hg

Diastolic: Blood pressure
BPXDI4
(fourth reading) mm Hg

CVD Morbidity Variables
Table 8
Ever had pain or discomfort in chest
Both males and females 40 YEARS - 150 YEARS
Code or Value

Value Description

1

Yes

2

No

7

Refused

9

Don't know

.

Missing

58
Table 9
Severe pain in chest more than half hour
Both males and females 40 YEARS - 150 YEARS
Code or Value

Value Description

1

Yes

2

No

7

Refused

9

Don't know

.

Missing

ICD Codes from the NDI
Tables 8 and 9, as well the ICD 9 Morbidity (Hospitalization) codes below,
contain the symptoms and conditions that indicate CVD morbidity in the sample. ICD 10
Mortality Codes below that are found in the NDI survey form the morbidity variable.
These codes are extracted by the NCHS from the NDI survey and linked to NHANES
data. The following list contain the ICD 9 and 10 codes that indicate CVD mortality
and/or morbidity outcomes in this research study.
Morbidity (Hospitalizations) from the NDI Survey: ICD-9 Codes
•

All Heart Disease: 390-398, 402, 404, 410-429; principle (i.e., first-listed)
diagnosis.

•

Coronary Heart Disease: 410-414, 429.2; principle (i.e., first-listed) diagnosis.

•

Acute Myocardial Infarction: 410; principle (i.e., first-listed) diagnosis.
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•

Cardiac Dysrhythmia: 427; principle (i.e., first-listed) diagnosis.

•

Heart Failure: 428; principle (i.e., first-listed) diagnosis.

•

Hypertension: 401-405; principle (i.e., first-listed) diagnosis.

Mortality from the NDI Survey: ICD-10 Codes
•

All Heart Disease: I00-I09, I11, I13, I20-I51; underlying cause of death.

•

Coronary Heart Disease: I20-I25; underlying cause of death.

•

Acute Myocardial Infarction: I21-I22; underlying cause of death.

•

Cardiac Dysrhythmia: I47-I49; underlying cause of death.

•

Heart Failure: I50; deaths with heart failure mentioned in any of the 20 listed
causes of death on the death certificate.

•

Hypertension: I10-I15; deaths with hypertension mentioned in any of the 20 listed
causes of death on the death certificate.

Data Analysis
SAS software was used to analyze the data. Descriptive statistics was used first to
describe the basic features of the data and provide summaries about the sample and the
measures. The best and worst groups will be identified according to the CVD morbidity
and mortality outcomes. Descriptive statistics were used to point out variables that
should be further examined. The CVD morbidity variables for chest pain and
hospitalization codes from ICD-9, as well as the ICD-10 Mortality Codes, were counted
to determine the number of CVD related morbidity and mortality diagnoses.
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Multivariate Analyses
Multivariate analyses were performed to assess associations between CVD
outcomes and multiple risk factors for CVD morbidity and mortality amongst those with
hypertension who may have numerous health disparities risk factors. The absolute,
relative and percent variations of the demographic variables for mortality and morbidity
were computed. Regression models were used to assist in investigating the relationships
between the dependent variables and the independent variables. Logistic regression was
used to analyze the CVD morbidity and mortality variables from the ICD-9 and ICD-10
codes to identify the relevant diagnoses. In addition, interaction variables were identified
and used with regression modelling to better understand the relationships among the
variables.
Absolute Difference and Relative Difference. The absolute difference is
calculated by subtracting the rate for a reference population from the rate from the other
populations. The relative difference is obtained by dividing the absolute difference by
the rate for the reference population and the result is expressed as a percentage of the rate
for the reference population. In this study, the absolute and relative differences in CVD
outcomes for racial/ethnic groups were calculated by identifying the Race/Ethnic group
with the best CVD outcomes and considering them to be the reference group. This
reference group is compared to the other Race/Ethnic groups.
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Table10 aligns the research questions with the relevant study variables and
statistical analyses that were utilized in this research study.

Table 10
Statistical Analyses
Research Questions
RQ1: Are there significant
differences in the selected
CVD morbidity outcomes
between hypertensive
subpopulations, ages 30
years and up, experiencing
health disparities and the
best group (i.e., the
subpopulation with the best
CVD morbidity outcomes)
in the United States for
hypertension and when
three or more indicators
(i.e., race, gender,
education, income)
intersect?
The following variables
include: CVD morbidity as
a dependent variable; age,
education level, household
income, race/ethnicity,
body mass index (BMI),
and gender are the
independent variables.
Other covariates are
hypertension medications,
taking cardiovascular
medications, smoking, and
cardiovascular fitness.

Variable(s)
Demographics:
Age, Gender,
Race/Ethnicity,
Education &
Income

Analyses
Descriptive Statistics

Bivariate Analysis
Hypertension
Indicators & CVD
Morbidity from
NDI
Demographics by
Morbidity
(Hospitalizations)
from NDI,
Hypertension
Indications and
CVD Covariates

Multivariate Analysis
Regression Models, Logistic Regression and
Interaction Variable
Absolute and Relative Differences
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RQ2: What are the
significant differences in
CVD mortality outcomes
between hypertensive
subpopulations
experiencing health
disparities and the best
group (i.e., the
subpopulation with the best
CVD mortality outcomes)
with hypertension in the
United States when three or
more indicators (i.e., race,
gender, education, income)
intersect? The following
variables that are relevant
to this question include:
CVD mortality as a
dependent variable;
education level, household
income, race/ethnicity,
BMI, and gender are the
independent variables.
Other covariates are:
hypertension medications,
taking cardiovascular
medications, smoking, and
cardiovascular fitness.

Demographic:
Age, Race,
Education, &
Income

Descriptive Statistics and Variable Scores

Hypertension
Indicators & CVD
Mortality from
NDI

Bivariate Analysis

Demographics by
Mortality from
NDI, Hypertension
Indications and
CVD conditions

Multivariate Analysis
Regression Models, Logistic Regression and
Interaction Variable
Absolute and Relative Differences

Research Questions and Hypotheses
The following research questions and hypotheses were used to test the cumulative
effect of demographic variables on CVD morbidity and mortality among persons with
hypertension in the United States.
RQ1: Are there significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations, ages 30 years and older, experiencing health
disparities and the best group (i.e., the subpopulation with the best CVD morbidity
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outcomes) in the United States for hypertension and when three or more of the following
indicators intersect?
Indicators among individuals within certain subpopulations include race, gender,
age, education, and income.
Selected CVD morbidity include reporting severe pain in the chest more than
half hour and pain or discomfort in chest reported by participants in NHANES. Coronary
heart disease, acute myocardial infarction, cardiac dysrhythmia, and heart failure reported
in NDI survey.
H10: There are no significant differences in cardiovascular disease morbidity
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
H1A: There are significant differences in cardiovascular disease morbidity
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
RQ2: What are the significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group (i.e., the subpopulation with the best CVD mortality outcomes) in the United
States for hypertension and when three or more of the following indicators intersect?
Indicators among individuals within certain subpopulations include race, gender,
age, education, and income.
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Selected CVD mortality include coronary heart disease, acute myocardial
infarction, cardiac dysrhythmia, and heart failure reported in the NDI survey.
H20: There are no significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
H2A: There are significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
Descriptive statistics, bivariate analyses, and multivariate analyses with
Regression Models were used to test the cumulative effect of demographic variables on
CVD morbidity and mortality among persons with hypertension in the United States for
the research questions and hypotheses. Specifically, descriptive statistics described the
basic features of the data and provided summaries. A bivariate analysis was conducted to
analyze hypertension and CVD to determine the empirical relationship between them, as
well as test simple hypotheses of association. Multivariate analyses were performed to
assess changes in the risk for CVD morbidity and mortality among those with
hypertension who may have numerous health disparities risk factors. The absolute,
relative and percent differences of the demographic variables for mortality and morbidity
were computed. The specific variables that were presented are the following dependent
variables: 1) CVD morbidity – hospitalizations for pain or discomfort in the chest and
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coronary heart disease, acute myocardial infarction, heart failure and cardiac dysrhythmia
diagnoses. 2) CVD mortality – death as a result of coronary heart disease, acute
myocardial infarction, heart failure and cardiac dysrhythmia diagnoses. Independent
variables are education level, age, household income, race/ethnicity, body mass index
(BMI), and gender. Having hypertension is an inclusion criterion for this study. Other
covariates are: hypertension medications, taking cardiovascular medications, smoking,
and cardiovascular fitness, cholesterol levels, and hemoglobin A1-C levels. This study
will use CVD event surveillance data and secondary data analysis to respond to the
research questions.
Descriptive statistics were performed on the following demographic variables:
age, gender, race/ethnicity, education and income. Bivariate analysis using the
hypertension indicators on CVD morbidity and mortality from the NDI. Regression
analyses will be done using the demographics by morbidity and mortality from NDI,
hypertension indications and CVD conditions. Interaction variables will be identified and
used with regression modelling to better understand the relationships among the
variables.
Threats to Validity
This study focuses on relationships between hypertension, cardiovascular disease
and indicators of health disparities. Given that this study is both cross-sectional and
correlational, causation was not assessed. Internal validity is much stronger for
experimental designs than for correlational designs. The interview portion of NHANES
is retrospective. Difficulty remembering is a major limitation of retrospective studies.
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For example, recalling if they were told that they had high blood pressure two or more
times may be difficult for some of the participants. This may result in inaccurate or
biased recall. Additionally, it cannot be assumed that correlation leads to causation.
Since the intent of this study is to determine if a relationship exist between the indicators
for health disparities and hypertension and CVD, a correlational design was appropriate
in spite of its limitations.
Ethical Procedures
NHANES serves as the primary data source for this research project. The ethical
concerns regarding access to participants and the treatment of data were addressed by the
researchers who plan and execute NHANES. Agreements to access data are not needed
because it is available for public use. Data were stored and maintained in an electronic
file on a computer that is password protected and will be kept for at least five years.
Human participation is not a factor because this is secondary data. However, all
guidelines were followed and relevant approval from Walden IRB regarding the
treatment of human subjects and data was obtained. Data was anonymous and
confidential. The primary researcher has access to the data along with the two committee
members.
Summary
This research study examined whether there are differences in health outcomes
among subpopulations with hypertension who have numerous demographic
characteristics that are health disparities indicators for CVD in comparison to
subpopulations with hypertension who have one or fewer health disparities indicators.
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This cross-sectional observational study analyzed multiple demographic characteristics
among people with hypertension that are indicators for health disparities and generalized
from large samples to the U.S. population using surveillance data from NHANES. The
demographic characteristics were analyzed and compared based on the relevant CVD and
hypertension variables from NHANES. The cumulative effect of variables was
determined by quantifying the variables that merge across CVD and morbidity and
mortality among people with hypertension in the study population to assess disparities
and changes in disparities.
The next chapter discusses the data analysis and results. In Chapter 4, the
cumulative effect of indicators (i.e., race, gender, education, and income) will be
analyzed to determine if there are significant differences in CVD morbidity and mortality
outcomes among hypertensive subpopulations experiencing health disparities.
Additionally, the multivariate analysis, the relative risks of the combined variables, and
the index of disparity results for each of the groupings will be analyzed.

Chapter 4: Results
Introduction
The purpose of this research was to explore the cumulative effect of demographic
characteristics such as race, gender, age, education, and income to determine if there are
significant differences in CVD morbidity and mortality outcomes among hypertensive
subpopulations that are linked to CVD and hypertension health disparities. The research
questions and hypotheses were:
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RQ1: Are there significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations, ages 30 years and older, experiencing health
disparities and the best group (i.e., the subpopulation with the best CVD morbidity
outcomes) in the United States for hypertension and when three or more of the following
indicators intersect?
H10: There are no significant differences in cardiovascular disease morbidity
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
H1A: There are significant differences in cardiovascular disease morbidity
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
RQ2: What are the significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group (i.e., the subpopulation with the best CVD mortality outcomes) in the United
States for hypertension and when three or more of the following indicators intersect?
H20: There are no significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
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H2A: There are significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect.
This chapter is organized into the following sections: data analysis, results, and
summary.
Data Collection
The data were collected by the NHANES from 1999-2010 from the U.S.
population residing in 15 counties per year in the United States (CDC, 2017). The 45,033
respondents from all age and gender groups were recruited from various counties across
the United States. 9,296 respondents with hypertension who were 30 years and older met
the criteria and were found to be eligible for the research study. It was also necessary to
identify study participants who were taking prescribed hypertension medication. There
were 8,781 participants with hypertension who stated that they were prescribed
medication to control their blood pressure. Additionally, 7,236 participants were
identified who stated that they are now taking prescribed hypertension medication).
Amongst people with hypertension, the hypertension medication use of the
subpopulations with at least two or more health disparity indicators were compared to
those with one or less health disparity indicator in Table 11 (CVD Morbidity) in order to
assess whether there was a confounding effect. It was found that no significant
difference in medication use existed between those persons with 0 to 1 health disparity
indicators (i.e., age, education, race, gender and income) who were taking hypertension
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medications and those with 2 or more health disparity indicators who were taking
medication for hypertension for CVD morbidity.
Table 11
Odds Ratios with Point Estimates for Persons Taking Hypertension Medication Among
Health Disparity Indicator Categories for Adults 30 Years and Older With Hypertension
for CVD morbidity
Hypertension Medication Use among
Health Disparity Indicator Categories

BP Medication Cat 2 vs 1
BP Medication Cat 3 vs 1
BP Medication Cat 4 vs 1

Point Estimates

(95% CL)

Odds Ratios
1.083

(0.896-1.307)

1.003

(0.811-1.240)

1.065

(0.761-1.491)

Table 12 contains the descriptions, types and coding for the independent and dependent
variables of this study. I found no discrepancies in the data collection for the plan that
was presented in Chapter 3. The sample included participants from all race/ethnicities
who were hypertensive, 30 years and older of both genders. A complex, multistage
probability design with a larger sample size is used by NHANES in order to increase the
reliability and accuracy of the health status of the target population, and to ensure the
representativeness of sample (CDC, 2015).
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Table 12
Independent and Dependent Variable Coding
Variables
Type of
Independent Variables
variable
Highest Education Level
Categorical
Achieved

Race/Ethnicity

Nominal

Poverty Income Ratio (PIR)

Categorical

Gender

Categorical

Age

Interval
Categorical

Told to take BP Medication

Categorical

Now Taking BP Medication

Categorical

Morbidity

Type of
Variable
Categorical

Mortality

Categorical

Hypertension

Categorical

Dependent Variables

Data coding
1= Less Than High School
2= High School Diploma
3=Some college or AA degree
4=College graduate or above
1=Caucasian or White
2=Black
3=Hispanic
4= Other Race (Including Multiracial)
1=Income below poverty level
0= Income above poverty level
1=Male
2=Female
30 Years and older
1=30-44 years
2=45-54 years
3=55-64 years
4=66-74 years
5=75-79 years
6=80+ years
1=Yes
2=No
1=Yes
2=No
Data coding
1=Yes
2=No
1=Yes
2=No
1=Yes
2=No
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Results
Data for this study were analyzed using SAS v. 9.4. The types and data coding for
the independent and dependent variables are listed in Table 12. The unweighted totals,
row percent, standard errors, and categories for the variables in this study are presented in
Table 13. The crude associations with unweighted frequencies and row percent for CVD
morbidity among hypertensive adults 30 years and older are presented in Table 14.
Participants who were between the ages of 66-74 years-old (n=505), male gender
(n=958), participants whose income is above the poverty level (n=1,259), Caucasians or
Whites (n=1,018), and persons with less than a high school diploma (n=709) had the
highest frequency in each of their categories. The crude associations with unweighted
frequencies and row percent for CVD mortality among hypertensive adults 30 years and
older are found in Table 15. Participants who were 80+ years-old (n=218), male gender
(n=350), participants whose income is above the poverty level (n=406), Caucasians or
Whites (n=345), and persons with less than a high school diploma (n=283) had the
highest frequency of CVD mortality in each of their categories. However, the findings
differed in many of the indicators when the dataset was analyzed to identify those
subpopulations who bear the highest burden of CVD-associated morbidity and mortality.
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Table 13.
Characteristics of U.S. Adults aged 30 Years and Older with Hypertension, 1999-2010,
n=9296.
Unweighted
Row
Standard
n
Percent
Error
Total
9296
Age
30-44 years
962
14.42
0.677
45-54 years
1474
23.22
0.737
55-64 years
2103
22.44
0.553
66-74 years
2346
21.09
0.525
75-79 years
939
8.25
0.354
80+ years
1472
10.57
0.405
Gender
Male
4514
46.84
0.569
Female
4782
53.16
0.569
PIR
Income below
poverty level
1513
11.93
0.512
Income above
poverty level
6981
88.06
0.512
Race/Ethnicity
Caucasian or
White
4744
73.73
1.49
Black
2266
13.75
1.084
Hispanic
2002
8.37
1.282
Other (Including
Multi-racial)
765
4.14
0.349
Education
Level
Less Than High
School
3402
24.76
0.735
High School
Diploma
2299
28.09
0.713
Some college
2172
27.15
0.783
College graduate
1398
19.99
0.793
CVD
Morbidity
1729
18.11
0.654
Mortality
599
1.21
0.259
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Table 14.
Crude Associations for CVD Morbidity Among Adults 30 Years and Older With
Hypertension, n=1,729.
Health Disparity
Indicators
Frequency
Percent

Age

Gender

Poverty Income Ratio
(PIR)

Race/Ethnicity

Education Level

30-44 years
45-54 years
55-64 years
66-74 years
75-79 years
80+ years

47
151
339
505
257
430

0.702
2.22
3.73
5.27
2.59
3.59

Male
Female
Income below poverty level

958
771
312

9.28
8.82
2.83

Income above poverty level

1259

15.17

White
Black
Mexican American
Other Race (Including Multiracial)

1018
388
219

14.08
2.35
0.539

104

1.14

Less Than High School
High School Diploma
Some college or AA degree
College graduate or above

709
431
403
180

5.98
5.16
4.74
2.21
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Table 15.
Crude Associations for CVD Mortality Among Adults 30 Years and Older With
Hypertension, n=599.
Health Disparity
Indicators
Age

Frequency

Percent

30-44 years
45-54 years
55-64 years
66-74 years
75-79 years
80+ years

17
38
79
162
85
218

0.227
0.531
0.690
1.322
0.701
1.539

Male
Female

350
249

2.231
2.779

Income below poverty level
Income above poverty level

130
406

0.925
3.987

345

3.867

135

0.683

85
34

0.033
0.307

283

1.8505

133

1.3358

126
55

1.297
0.5312

Gender

PIR

Race/Ethnicity
Caucasian or White
Black
Hispanic
Other Race (Including
Multi-racial)
Education Level
Less Than High School
High School Diploma
Some college or AA degree
College graduate or above
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Research Question 1
I derived the following statistical findings from two primary research questions
and associated hypotheses that were aligned with the relevant study variables and
statistical analyses.
RQ1: Are there significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations, ages 30 years and older, experiencing health
disparities and the best group (i.e., the subpopulation with the best CVD morbidity
outcomes) in the United States for hypertension and when three or more of the following
indicators intersect? (Health disparity indicators-age, gender, PIR, race/ethnicity, and
education level).
H01: There are no significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations experiencing health disparities and the best group
with hypertension in the United States when three or more indicators intersect was the
null hypothesis that was rejected. Of the 9,296 participants with hypertension, there were
686 cases of CVD reported. I conducted multivariable analyses within and across the
five disparity indicators (i.e., age, sex, race/ethnicity, poverty-income ratio, and education
level) to examine CVD morbidity among participants with hypertension who are 30 years
and older. As indicated in Table 16, CVD morbidity increased as: participants got older
(i.e., participants who were 80+ years-old were ten times more likely than those who
were between the ages of 30-44 years); in males versus females; participants with
incomes below the poverty level were 1.5 times more likely to report CVD morbidity
than those whose income was above the poverty level; and in those participants who are
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Black. Participants were also less likely to experience CVD morbidity as their education
level increased. Those with less than high school education were 2.5 times more likely to
report CVD morbidity in comparison to participants who were college graduates are
above.
Table 16.
Odds Ratios with Point Estimates for CVD Morbidity Among Adults 30 Years and Older
With Hypertension, n=9,296.
Point Estimates
(95% CL)
Odds Ratios
Age
30-44 years
Comparison grp.
45-54 years
1.974
(1.311-2.972)
3.752
(2.476-5.686)
55-64 years
66-74 years
6.505
(4.515-9.370)
75-79 years
8.791
(6.202-12.460)
80+ years
10.153
(6.878-14.989)
Sex
Male
Comparison grp.
Female
0.766
(0.673-0.873)
Poverty-income ratio
Income below poverty level
1.544
(1.308-1.822)
Income above poverty level
Comparison grp.
Race/ethnicity
Comparison grp.
Caucasian or White
Black
0.890
(0.755-1.050)
Hispanic
0.641
(0.520-0.790)
0.716
(0.488-1.049)
Other Race (Including Multi-racial)
Education level
Less Than High School
High School Diploma
Some college or AA degree
College graduate or above

2.514
1.837
1.741
Comparison grp.

(2.035-3.107)
(1.420-2.375)
(1.397-2.169)

I determined health disparities among people with hypertension in this research
study by identifying those subpopulations within the health disparity indicators (i.e., age,
gender, PIR, race/ethnicity, and education level) who were bearing the highest burden of
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CVD morbidity. I assessed interactions between the health disparity indicators and
morbidity outcomes by assigning Health Disparity Indicator Scores to the health disparity
indicators. The subcategories in the health disparity indicators were assigned a score of 0
for the comparison group (i.e., college graduate or above for education level) or 1 for the
group with the highest disparity (i.e., less than high school for education level).
According to Table 17, there were significant differences in CVD morbidity outcomes
between hypertensive subpopulations experiencing health disparities when three or more
indicators intersect in comparison to 0 or 1 health disparity indicator.

Table 17
Odds Ratios with Point Estimates for Health Disparity Indicator Scores for CVD
Morbidity Among Adults 30 Years and Older With Hypertension
Number of Health Disparity Indicators
Point Estimates
(95% CI)
(HDI)
Odds Ratios

HDI 1 vs. 0

9.215

(1.969-43.131)

2 vs. 0

12.797

(2.725-60.093)

3 vs. 0

15.710

(3.232-76.356)

4 vs. 0

12.516

(2.544-61.580)

However, Health Disparity Indicator Score Categories for the health disparity
indicators (i.e., age, gender, PIR, race/ethnicity, and education level) were created to
combine scores with small frequencies and large confidence intervals. Category 1
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contains 0 to 1 health disparity indicators, Category 2 contains two health disparity
indicators, category 3 contains 3 health disparity indicators, and category 4 contains 4 to
5 health disparity indicators. Table 18 shows that the CVD morbidity increases
significantly as the number of health disparity indicators increase. There were significant
differences in CVD morbidity outcomes between hypertensive subpopulations who were
30 years and older experiencing health disparities when up to three health disparity
indicators intersect in comparison to participants with 0 to 1 health disparity indicator.
Table 18.
Odds Ratios with Point Estimates for Health Disparity Indicator Score Categories for
CVD Morbidity Among Adults 30 Years and Older With Hypertension
Number of Health Disparity Indicator
Categories

Point Estimates

(95% CL)

HDI Cat 2 vs 1
Cat 3 vs 1

1.519
1.864

(1.208-1.908)
(1.421-2.446)

Cat 4 vs 1

1.485

(1.024-2.154)

Odds Ratios

It should also be noted that point estimates for Health Disparity Indicator Score
Categories for CVD morbidity among adults 30 years and older were higher for all adult
participants (i.e., with and without hypertension) than for the hypertensive study
participants according to Table 19.
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Table 19.
Odds Ratios with Point Estimates for Health Disparity Indicator Score Categories for
CVD Morbidity Among Adults 30 Years and Older
Number of Health Disparity Indicator
Pt. Estimates
(95% CL)
Categories
Odds Ratios
Category 2 vs 1
Category 3 vs 1

2.210
2.833

(1.842-2.652)
(2.242-3.580)

Category 4 vs 1

3.201

(2.364-4.335)

Research Question 2
RQ2: What are the significant differences in CVD mortality outcomes between
hypertensive subpopulations experiencing health disparities and the best group (i.e., the
subpopulation with the best CVD mortality outcomes) in the United States for
hypertension and when three or more of the following indicators intersect? (Health
disparity indicators-age, gender, PIR, race/ethnicity, and education level).
H02: There are no significant differences in CVD mortality outcomes between
hypertensive subpopulations experiencing health disparities and the best group with
hypertension in the United States when three or more indicators intersect was the null
hypothesis that was rejected. Multivariable analyses were conducted within and across
the five disparity indicators to examine CVD mortality among participants with
hypertension who are 30 years and older. As indicated in Table 20, CVD mortality
hazard ratios increased as: participants got older (i.e., the hazard ratio was 21.1 for
participants who were 80+ years-old in comparison to 1.00 for those who were between
the ages of 30-44 years); in males versus females; participants with incomes below the
poverty level was 1.8 times more likely to report CVD mortality than those whose
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income was above the poverty level; and in those participants who are Caucasian or
White. Participants were also less likely to experience CVD mortality as their education
level increased. Those with less than high school education were 3 times more likely to
report CVD mortality in comparison to participants who were college graduates are
above.
Table 20.
Hazard Ratios with Point Estimates for CVD Mortality Among Adults 30 Years and
Older With Hypertension
Point Estimates
Hazard Ratios
Age
30-44 years
Comparison grp.
1.000
45-54 years
0.6144
1.849
55-64 years
0.9466
2.577
66-74 years
1.7268
5.623
75-79 years
2.1616
8.685
80+ years
3.0521
21.16
Sex
Male
Comparison grp.
1.000
Female
-0.3909
0.676
Poverty-income ratio
Income below poverty level
0.6067
1.834
Income above poverty level
Comparison grp.
1.000
Race/ethnicity
White
Comparison grp.
1.000
Black
-0.0869
0.917
Hispanic
-0.4001
0.670
Other Race (Including Multi-racial)
-0.4957
0.609
Education level
Less Than High School
1.1377
3.120
High School Diploma
0.7089
2.032
Some college or AA degree
0.6906
1.995
College graduate or above
Comparison grp.
1.000
Interactions were assessed between disparity indicators by assigning Health
Disparity Indicator Scores to the health disparity indicators. According to Table 21, there
were significant differences in CVD mortality outcomes between hypertensive
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subpopulations experiencing health disparities when three or more health disparity
indicators intersect.
Table 21.
Odds Ratios with Point Estimates for Health Disparity Indicator Scores for CVD
Mortality Among Adults 30 Years and Older With Hypertension
Number of Health
Pt. Estimates (95% CL)
Frequency
Standard
Error
Disparity Indicators
Odds Ratios
HDI Score=0

Comparison
grp.
5.881

82

0.281

(3.43410.073)

86

0.7474

9.512

(5.48416.498)

2978

0.6664

12.192

(6.71722.129)

2149

0.6339

13.771

(7.51525.235)

1207

0.3421

1 vs. 0
2 vs. 0
3 vs. 0
4 vs. 0

Health Disparity Indicator Score Categories were created to combine scores with
small frequencies and large confidence intervals. Category 1 contains 0 to 1 health
disparity indicators, category 2 contains 2 health disparity indicators, category 3 contains
3 health disparity indicators, and category 4 contains 4 to 5 health disparity indicators.
Table 22 shows that the CVD mortality increases significantly as the number of health
disparity indicators increase (i.e., hazard ratios were 1.59 and 2.44 for 3 and 4 or more
health disparity indicators in comparison to 0 to 1 health disparity indicator). There were
significant differences in CVD mortality outcomes between hypertensive subpopulations
who were 30 years and older experiencing health disparities when three or more
indicators intersect in comparison to participants with 0 to 1 health disparity indicator.
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Table 22.
Health Disparity Indicator Score Categories with Hazard Ratios Among Adults 30 Years
and Older With Hypertension
Number of CVD Death
Point Estimates
Standard Errors Hazard Ratios
Disparity Indicator Categories
HDI Cat 1
HDI Cat 2 vs Cat 1

0
0.4809

1.000
0.176

1.618

HDI Cat 3 vs Cat 1

0.4636

0.252

1.590

HDI Cat 4 vs Cat 1

0.8942

0.215

2.445

Summary
In summary, findings of this study indicated that there were significant
differences in CVD morbidity outcomes between hypertensive subpopulations who were
30 years and older experiencing health disparities when up to three health disparity
indicators intersect in comparison to participants with 0 to 1 health disparity indicator. It
was also found that these significant differences in CVD morbidity outcomes also exist
among all adults 30 years and older with and without hypertension when up to four health
disparity indicators intersect in comparison to participants with 0 to 1 health disparity
indicator. Additionally, there were significant differences in CVD mortality outcomes
between hypertensive subpopulations in the United States who were 30 years and older
experiencing health disparities when three or more health disparity indicators intersect.
Chapter 5 will discuss the interpretation of the findings, the limitations, the
recommendations, and the implications of the study.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this research was to investigate whether significant differences in
CVD morbidity and/or mortality outcomes existed between persons with hypertension
who experience three or more health disparities indicators and the best identified group
with hypertension in the United States. I designed this cross-sectional quantitative study
to determine the significance of the convergence of multiple indicators for health
disparities (i.e. race, gender, education, income, and age) on the CVD outcomes of people
with hypertension. The research population consisted of NHANES participants with
hypertension, ages 30 years and older, for the years 1999 to 2010.
I assessed the descriptive statistics, bivariate analyses, multivariate analyses, odds
ratios, hazard ratios, as well as interactions between health disparity indicators in the data
analyses. Independent variables were education level, age, poverty income ratio, highest
education level completed, race/ethnicity, and gender. The dependent variables were
CVD morbidity and CVD mortality. I performed this research study was to investigate
whether the intersection of at least three of the independent variables had an impact on
the prevalence of CVD morbidity and mortality among 1999 to 2010 NHANES
participants with hypertension between the ages of 30 years and up. I considered the
impact of blood pressure medication. I also identified those participants with
hypertension who were taking prescribed medication to control their blood pressure. Key
findings from the data analysis showed that the following null hypotheses could be
rejected. First, there are no significant differences in cardiovascular disease morbidity
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outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect. Second, there are no significant differences in cardiovascular disease mortality
outcomes between hypertensive subpopulations experiencing health disparities and the
best group in the United States for hypertension and when three or more indicators
intersect. This means that NHANES 1999-2010 participants who were at least 30 yearsold with hypertension were more likely to be affected by CVD morbidity and mortality as
a result of the cumulative effect of at least three health disparities indicators.
Interpretation of Findings
It is well-established in the literature that certain populations experience health
disparities and are disproportionately impacted by CVD and hypertension. According to
Duran and Perez-Stable (2019), there are research findings which “demonstrate that
health disparities exist, even without poverty, and with high education and adequate
access to care” (p. S8). The emphasis of this study was on hypertension and its impact on
certain populations. According to the Institute of Medicine (IOM) in 2010, it was
estimated that direct and indirect hypertension costs were 73.4 billion in 2009 alone.
This research study extends the knowledge base. My research found that there were
significant differences in CVD morbidity and mortality outcomes between hypertensive
subpopulations experiencing health disparities and the best group in the United States
(i.e., the hypertensive subpopulations with 0-1 HDI) when three or more health
disparities indicators intersect. The impact of blood pressure must be considered
alongside other risk factors. This aligns with what was described in the literature review
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(Ritchey, et al., 2014; Duran and Perez-Stable, 2019) and is reinforced in the findings of
this research. Education, age, gender, poverty income ratio, and race/ethnicity are the
health disparities indicators that were used as independent variables. There are also risk
factors for hypertension that must be considered. The following risk factors contributed
substantially to the burden of hypertension: overweight and obesity, high sodium intake,
unhealthy diet, and decreased physical activity (Institute of Medicine, 2010).
Gender, age, education, race/ethnicity, and poverty-income ratio on the national
level among adults are the health disparity indicators that were the foci of this research.
Interventions and policies that are needed to eliminate these health disparities are farreaching and include social determinants of health that often exceed the resources and
capabilities of public health. Population-based policy interventions and interventions
directed at systems-level improvements should be considered when seeking ways to
prevent hypertension in the general population, as well as those who are
disproportionately impacted. In a report brief titled: A Population-based Policy and
Systems Change Approach to Prevent and Control Hypertension, the Institute of
Medicine (2010) suggests integrating hypertension prevention and control interventions
into the policies and programs of public health practices in ways that ways that not only
support healthy eating, active living, and obesity, but also align their with populations
who are most likely to be affected by hypertension. These efforts should be multifaceted.
According to Agurs-Collins, et al. (2019), the wide ranging and multi-faceted factors that
cause health disparities comprise every level of the socioecological model. From a
research perspective, the National Institutes of Health has appealed for more research
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utilizing a multi-level approach to address the health needs of disadvantaged populations
(Agurs-Collins, et al., 2019). This reinforces the theoretical basis of this research study.
In the next section I describe the two research questions with the accompanying
null hypotheses and alternative hypotheses. I also discuss whether each of the alternative
hypotheses were supported by my research findings.
Research Question One
RQ1: Are there significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations, adults who are 30 years and older, experiencing
health disparities and the best group (i.e., the subpopulation with the best CVD morbidity
outcomes) in the United States for hypertension and when three or more indicators (race,
gender, education, age and income) intersect?
H01: There are no significant differences in the selected CVD morbidity
outcomes between hypertensive subpopulations experiencing health disparities and the
best group with hypertension in the United States when three or more indicators intersect.
Ha2: There are significant differences in the selected CVD morbidity outcomes
between hypertensive subpopulations experiencing health disparities and the best group
with hypertension in the United States when three or more indicators intersect. The
results of this research study supported the alternative hypothesis for three or more health
disparity indicators among people with hypertension 30 years or older.
Many of the disparities that were discussed in the literature review were supported
in the findings of my research. The findings of the study showed that CVD morbidity
increased as participants: got older; in males versus females; when incomes were below
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the poverty level; among Blacks; and among those with less than high school education.
This is confirmed by findings in the literature review that examined up to two health
disparity indicators (Liao, et al., 2011; Liu, et al., 2011; Ritchey, et al., 2014). This
research study expands the knowledge base by examining the morbidity and mortality
CVD outcomes that result from the intersection of three or more health disparity
indicators. There were significant differences in CVD morbidity outcomes between
hypertensive subpopulations who were 30 years and older experiencing health disparities
when three health disparity indicators intersect in comparison to participants with 0 to 1
health disparity indicator. In similar research study by Gupta (2014), the researcher
examined multiple risk factors for CVD in Delaware using the BRFSS. The researcher
found that more persons with CVD reported multiple risk factors. Additionally, the
prevalence of multiple risk factors was higher for the aged, less educated, and
unemployed (Gupta, 2014).
Research Question Two
RQ2: What are the significant differences in CVD mortality outcomes between
hypertensive subpopulations experiencing health disparities and the best group (i.e., the
subpopulation with the best CVD mortality outcomes) with hypertension in the United
States when three or more indicators (race, gender, education, age and income) intersect?
H02: There are no significant differences in CVD mortality outcomes between
hypertensive subpopulations experiencing health disparities and the best group with
hypertension in the United States when three or more indicators intersect. Ha2: There are
significant differences in CVD mortality outcomes between hypertensive subpopulations
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experiencing health disparities and the best group with hypertension in the United States
when three or more indicators intersect. The research study results found that the
alternative hypothesis was correct for three health disparity indicators among persons 30
years or older with hypertension.
The likelihood of CVD mortality increased in the research study as: participants
got older; in males; with incomes below the poverty level; in Whites; and among those
with less than high school education. This is consistent with the findings of Perez-Stable,
(2019) in the literature review. Regarding the CVD mortality outcomes, it must also be
noted that Whites were found to be disproportionately impacted. This differs with a
study in the literature review that found higher mortality rates among hypertensive men
than hypertensive women, and among hypertensive Blacks than hypertensive Whites
(Ford, 2011). However, the research finding in this study regarding Whites does relate to
the finding in another study that CVD is a more common cause of death at older ages and
that Whites were found to have a higher life expectancy in comparison to most other
race/ethnic groups in the United States (Kochanek et al., 2015).
My research study found significant differences in CVD mortality outcomes
between hypertensive subpopulations experiencing health disparities when three or more
health disparity indicators intersect in comparison to 0 to 1 health disparity indicator. I
also found that the higher HDI groups were associated with worse CVD outcomes overall
regardless of hypertensive status. No comparison research was published in the literature
at the time of this research study.
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Theoretical Framework: Systems Theory
The findings of this research suggest that when three or more health disparity
indicators intersect in persons with hypertension, then this may result in a cumulative
effect that exacerbates CVD morbidity and mortality. In addition to the impact of health
disparities and the social determinants of health, Duran and Perez-Stables (2019) stated
that developments in science suggest additional health determinants need to be
considered in multilevel etiologic analyses to understand the contributors of health
disparities. According to Argur-Collins, et al., (2019), “the factors that underlie
disparities are wide ranging and multifaceted; these factors encompass every
socioecological level, including individual, interpersonal, community, and societal” (p.
S86). These multilevel interventions can be tailored to focus on specific subpopulations.
For example, Timmons, et al. (2017) described a patient-centered intervention that aligns
with Systems theory and the socioecological model which addresses hypertension-related
health disparities. The researchers identified three multilevel elements (i.e., social
support, lifestyle coaching, and personalized medical management) that are believed to
be critical components of interventions that can successfully manage hypertension in atrisk Blacks.
Limitations of the Study
The NHANES survey was the source of the large data sample but such factors as
selection bias and response rate may have impacted the research study outcomes.
Limitations in areas such as generalizability, validity, trustworthiness, and reliability
arose from my execution of this cross-sectional correlational study. Generalizability is
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limited because this is a correlational study that in which causation cannot be assumed.
My findings also cannot be generalized to noninstitutionalized populations. I also have
concerns regarding internal validity and trustworthiness because of the health interview
portion of the data collection. The health interview relies on the participant to remember
specific events which subjects the study to recall bias. Difficulty with memory among
the participants was also a limitation. Finally, data from the NHANES survey was
collected during the years of 1999 to 2010 for this research study. The age of the dataset
is also a limitation that must be considered.
I did not analyze the confounding variables such as smoking, obesity, and
diabetes that may also influence CVD outcomes in this study. As result, this may
indicate the need for further research that includes these contributing factors.
Additionally, the impact of taking hypertension medication must also be considered
across the health disparity indicators. When I compared taking hypertension medication
across the health disparity indicators, there were no significant difference across them
with 95% CIs, and 1.08, 1.00- and 1.06-Point Estimates for Health Disparity Indicator
Categories vs. Taking Hypertension Medication.
Recommendations for Study
Findings from this research study showed that there were significant differences
in CVD morbidity and mortality outcomes between hypertensive subpopulations
experiencing health disparities and the best group in the United States for hypertension
when three or more indicators intersect amongst 1999-2010 NHANES participants 30
years and older.
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I suggest the following recommendations as I considered the strengths and
limitations of this research study based on the literature that I reviewed. The principles of
Systems theory can be applied to future interventions that are designed to eliminate the
health inequities and address the social determinants of health that are associated with
hypertension and CVD. The theoretical framework that Systems theory provides should
be used in future research to examine the relationships between different subareas of
health disparities indicators related to hypertension and CVD. The outcome of this
research study suggests that more research and public health interventions are needed on
issues related to hypertension and CVD among subpopulations who are impacted by
multiple health disparity indicators (i.e., three or more) and risk factors. Additional
research that compares hypertension and CVD health outcomes of people with
hypertension and non-hypertensives, as well as comparing those who take hypertension
medication with those who do not take hypertension medication is needed. Confounding
variables such as smoking, obesity, and diabetes that may also influence CVD outcomes
were not analyzed in this study. As result, this may indicate the need for further research
that includes these contributing factors.

Implications for Positive Social Change
The findings of my research study may have potential impact on hypertension and
CVD morbidity and mortality outcomes through changes in clinical and public health
practice by increasing the knowledge and awareness of providers, public health
practitioners, and policymakers. Healthcare practitioners and providers can utilize the
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findings of this study to increase focus on those patients with multiple health disparity
indicators. Other changes in clinical practice may result in the use of clinical data and
aggregate reports to pinpoint gaps in clinical care for patients (such as patients that are
hiding in plain sight or patients that are diagnosed, but uncontrolled) and implement
innovative activities to improve health outcomes among the patient population. Public
health practitioners could use the results of this research study to enhance surveillance
and tailor interventions to serve persons with hypertension who are faced with multiple
health disparity indicators. Public health practice may be expanded to address the social
determinants of health by directly impacting care such as medication coverage/costs,
transportation to medical appointments, housing instability and food insecurity.
Policymakers are also crucial to the needs of persons with hypertension. They can
develop and promote policies that address the multiple health disparities and social
determinants of health that impact the health outcomes of persons with hypertension. If
this is achieved, then this research may contribute to positive social change by
contributing to the reduction of morbidity and mortality from CVD, decreasing the
burden of hypertension, improving the quality of life, and impacting positive changes on
multiple levels (i.e., individual, interpersonal, organizational, community, and public
policy) of society.
Systems theory was used as the theoretical basis which has implications when
exploring the connections between multiple perspectives, components, and subareas on
the macro level. Its focus on the inter-relations of multiple perspectives from complex
systems, multiple variables, as well as the ability to simultaneously explore these
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connections between different components and subareas on the macro level is relevant.
In their study outlining the skills needed and the challenges associated with multilevel
interventions, Agurs-Collins et al., (2019) recommends that resources are directed to
multilevel interventions that target the broader community, societal, and environmental
contexts that produce greater reductions in health disparities versus approaches targeting
a single level. The findings from this research study may help to advance public health
practice, generate new research, and influence clinical practice by contributing to the
knowledge base in the areas of CVD and hypertension health inequities and health
disparities.
Conclusion
In conclusion, I utilized a cross sectional quantitative study design to examine
whether there were significant differences in the selected CVD morbidity and mortality
outcomes between hypertensive subpopulations of adults who are 30 years and older,
experiencing health disparities and the best group (i.e., the subpopulation with the best
CVD morbidity outcomes) in the United States for hypertension and when three or more
health disparity indicators (race, gender, education, age and income) intersect. The
findings showed that there were significant differences among people with hypertension
in morbidity and mortality CVD outcomes when three or more health disparity indicators
intersected. Education, income, gender, poverty income ratio, and race/ethnicity are key
health disparities indicators that intersect and must be considered when seeking ways to
reduce hypertension and CVD inequities among persons 30 years and older who are at an
increased risk of CVD morbidity and mortality.
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